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Recent findings of brown adipocytes and brown-like or beige adipocytes, capable 
of dissipating energy as heat, in adult humans have promised new hope for obesity 
treatment and prevention. Understanding of the regulation of brown and beige 
adipocytes will provide novel strategies to reach the goal. Pattern recognition receptors 
(PRR) are responsible for inflammation in adipose tissue, which leads to adipose 
dysfunction and obesity associated chronic diseases. It has been shown that PRR 
activation induces inflammation, leading to insulin resistance in white adipocytes and 
white adipose tissue (WAT). However, the roles of PRR activation in brown adipocytes 
and brown adipose tissue (BAT) have not been studied. In addition, in vitro and in vivo 
studies have shown that bioactive food components can contribute to obesity 
prevention; however, very few bioactive food components have been studied for their 
beneficial effects in promoting development and function of brown and beige 
adipocytes. 
This dissertation reports that (1) mRNA of PRRs and inflammatory 
cytokines/chemokines are upregulated in the BAT of both diet induced obesity mice 
model and ob/ob mice model; (2) activation of PRRs induces activation of NF-κB and 
MAPK signaling pathways, leading to upregulation of the proinflammatory genes, MCP-
1, IL-6, RANTES, and TNF-α, in mature brown adipocytes; (3) activation of PRRs 
suppresses UCP-1 expression, leading to decreased mitochondrial respiration and 
thermogenesis in mature brown adipocytes; (4) chronic activation of PRRs reduces 
adipogenesis and suppresses expression of brown-specific genes in both classic brown 
adipocytes and multipotent stem cells. This dissertation further demonstrates that 
vi 
 
naringenin, a flavanone mainly found in citrus fruits, enhances thermogenic activation in 
isoproterenol-stimulated 3T3-L1 adipocytes through PKA/p38 MAPK pathways.  
The results suggest that PRR-mediated inflammation in brown adipocytes may 
be a potential target for regulating BAT development and function for obesity treatment 
and prevention. Dietary bioactive compounds, such as naringenin, could be beneficial in 





TABLE OF CONTENTS 
 
INTRODUCTION ............................................................................................................. 1 
CHAPTER I LITERATURE REVIEW .............................................................................. 4 
1.1 Obesity and adipose tissue ..................................................................................... 5 
1.1.1 Obesity and metabolic disease ......................................................................... 5 
1.1.2 Anatomy of adipose tissue: WAT and BAT ....................................................... 6 
1.1.3 Functions of adipose tissue: WAT and BAT ...................................................... 8 
1.2 Chronic inflammation in obesity ............................................................................ 11 
1.2.1 Adipose inflammation in obesity ...................................................................... 11 
1.2.2 Role of the pattern recognition receptor in adipose inflammation ................... 14 
1.3 Novel targets for obesity treatment and prevention: Brown and beige adipocytes 19 
1.3.1 Browning and beige ........................................................................................ 19 
1.3.2 Origins of brown and beige adipocytes ........................................................... 21 
1.3.3 Regulation of BAT development and function ................................................. 22 
1.3.4 Regulation of the browning process ................................................................ 26 
1.3.5 Nutritional intervention of BAT development and browning ............................ 30 
1.4 References ........................................................................................................... 35 
CHAPTER II ACTIVATION OF PATTERN RECOGNITION RECEPTORS IN BROWN 
ADIPOCYTES INDUCES INFLAMMATION AND SUPPRESSES UNCOUPLING 
PROTEIN 1 EXPRESSION AND MITOCHONDRIAL RESPIRATION .......................... 53 
2.1 Abstract ................................................................................................................ 55 
2.2 Introduction ........................................................................................................... 57 
viii 
 
2.3 Materials and methods ......................................................................................... 61 
2.4 Results .................................................................................................................. 67 
2.5 Discussion ............................................................................................................ 74 
2.6 References ........................................................................................................... 81 
2.7 Appendix ............................................................................................................... 85 
CHAPTER III CHRONIC ACTIVATION OF PATTERN RECOGNITION RECEPTORS 
SUPPRESSES BROWN ADIPOGENESIS OF MULTIPOTENT MESODERMAL STEM 
CELLS AND BROWN PRE-ADIPOCYTES .................................................................. 96 
3.1 Abstract ................................................................................................................ 98 
3.2 Introduction ........................................................................................................... 99 
3.3 Materials and methods ....................................................................................... 102 
3.4 Results ................................................................................................................ 107 
3.5 Discussion .......................................................................................................... 114 
3.6 References ......................................................................................................... 119 
3.7 Appendix ............................................................................................................. 123 
CHAPTER IV NARINGENIN, A CITRUS FLAVANONE, ENHANCES 
ISOPROTERENOL STIMULATED THERMOGENIC ACTIVATION OF 3T3-L1 
ADIPOCYTES VIA PKA/P38 PATHWAYS ................................................................. 134 
4.1 Abstract .............................................................................................................. 136 
4.2 Introduction ......................................................................................................... 137 
4.3 Materials and Methods ....................................................................................... 139 
4.4 Results ................................................................................................................ 144 
4.5 Discussion .......................................................................................................... 147 
ix 
 
4.6 References ......................................................................................................... 151 
4.7 Appendix ............................................................................................................. 154 
CONCLUSION AND FUTURE DIRECTION ............................................................... 162 





LIST OF FIGURES 
 
Figure 1 mRNA expression of selected PRRs are up-regulated in brown fat tissue of 
DIO and ob/ob mice .......................................................................................... 86 
Figure 2 Expression of selected PRRs are up-regulated during brown adipocyte 
differentiation ..................................................................................................... 87 
Figure 3 PRR activation in brown adipocytes induces phosphorylation and activation of 
NF-κB and MAPK signaling ............................................................................... 88 
Figure 4 PRR activation in brown adipocytes up-regulates the expression and secretion 
of proinflammatory cytokines/chemokines ........................................................ 89 
Figure 5 Inhibition of NF-κB attenuates mRNA expression of proinflammatory 
cytokines/chemokines induced by PRR activation ............................................ 90 
Figure 6 Inhibition of MAPK differentially attenuates mRNA expression of 
proinflammatory cytokines/chemokines induced by PRR activation .................. 91 
Figure 7 PRR activation suppresses both basal and isoproterenol-induced UCP-1 
expression, but not mitochondrial biogenesis, in brown adipocytes .................. 92 
Figure 8 PRR activation suppresses mitochondrial respiration in brown adipocytes .... 94 
Figure 9 Selected PRRs are expressed and functional during commitment and 
differentiation of multipotent mesodermal stem C3H10T1/2 cells ................... 124 
Figure 10 Chronic activation of NOD1, TLR4, or TLR2 suppresses brown-like adipocyte 
differentiation of C3H10T1/2 cells ................................................................... 126 
Figure 11 Molecular insights into the mechanisms by which chronic PRR activation 
suppresses brown-like differentiation of C3H10T1/2 ....................................... 127 
xi 
 
Figure 12 PRR activation only during the commitment phase is sufficient to lead to 
suppression of brown-like differentiation of C3H10T1/2 cells .......................... 128 
Figure 13 Molecular insights into the mechanisms by which PRR activation only during 
the commitment suppresses brown-like differentiation of C3H10T1/2 cells .... 129 
Figure 14 PRR activation suppresses the commitment to brown-like adipocytes of 
C3H10T1/2 cells .............................................................................................. 130 
Figure 15 Chronic activation of NOD1, TLR4, or TLR2 suppresses terminal 
differentiation of immortalized brown preadipocytes derived from BAT of mice
 ........................................................................................................................ 131 
Figure 16 Activation of PRR suppresses PPARγ transactivation through NF-κB pathway
 ........................................................................................................................ 133 
Figure 17 Effect of naringenin on mRNA expression of brown adipose specific markers
 ........................................................................................................................ 155 
Figure 18 Effect of naringenin on mitochondrial respiration in isoproterenol induced 
3T3-L1 adipocytes ........................................................................................... 156 
Figure 19 Effect of naringenin on PKA activation ....................................................... 157 
Figure 20 The effect of naringenin on the phosphorylation of p38 MAPK................... 158 
Figure 21 Effect of naringenin on PPARγ and PPRE transactivation ......................... 159 
Figure 22 Regulation of UCP-1 gene expression by pharmacological inhibitors for 
PKA/p38 MAPK signaling pathway ................................................................. 160 
Figure 23 Schematic diagram of activation of β-adrenergic receptor-stimulated signaling 






Obesity is a major health concern in the US: over 70% of adults are overweight 
(BMI of 25 to 29.9) or obese (BMI of 30 and over). Obesity leads to metabolic diseases 
including heart disease, stroke, and diabetes (National Institutes of Health, 2011). 
Obesity is caused by excess of energy intake that exceeds energy expenditure. Food is 
a major source of energy intake, while physical activity and basic metabolism rate are 
the major contributors to energy expenditure (Church et al., 2011; Hill, Wyatt, & Peters, 
2012). Physiologically, obesity is defined as excessive fat accumulation mostly in 
adipose tissue; hence, excess of adipose tissue is a hallmark of obesity. White adipose 
tissue (WAT) and brown adipose tissue (BAT) are the main types of adipose tissue in 
humans. WAT stores excess energy in the form of triglycerides whereas BAT dissipates 
energy through non-shivering thermogenesis, or heat production (Y. H. Lee, Mottillo, & 
Granneman, 2014).  
It is well recognized that obesity is associated with inflammation in adipose 
tissue, characterized by elevated proinflammatory cytokine/chemokine expression and 
infiltration of immune cells and that adipose inflammation is the starting point for 
dysfunction of adipose tissue and lipid metabolism, leading to obesity associated 
chronic diseases (Eto et al., 2009). It has been demonstrated that pattern recognition 
receptors (PRRs), including Toll-like receptors (TLRs) and Nucleotide-oligomerization 
domain-containing protein-like receptors (NLRs), play important roles in innate immune 
response and mediating adipose inflammation (Jin, Henao-Mejia, & Flavell, 2013; 
Takeuchi & Akira 2010). PRRs are responsible for the sensing of invading microbial 
pathogens leading to distinct inflammatory and immune responses in the host cells.  
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In contrast to WAT’s function for energy storage, BAT is a specialized tissue 
whose function is to produce heat through nonshivering thermogenesis via the functions 
of uncoupling protein 1 (UCP-1). UCP-1 proteins are localized in the inner membrane of 
brown adipocyte mitochondria to uncouple ATP synthesis from respiration. Newborn 
infants have BAT and that BAT quickly regresses following birth. However, new 
evidence from positron emission tomography/computed tomography scanning has 
revealed symmetrical fat depots in adults that have classical BAT features (Cypess et 
al. 2009; van Marken Lichtenbelt et al. 2009). Therefore, BAT has become a novel 
target for obesity treatment and prevention. While it has been reported that activation of 
PRRs increases inflammatory response and insulin resistance in WAT and white 
adipocytes (Pierre et al., 2013; Song et al., 2006; Zhao et al. 2011), the role of PRR-
mediated inflammation in regulating the function of BAT and brown adipocytes has not 
been studied.   
Recent evidence has also reported inducible brown-like adipocytes, also known 
as beige adipocytes, in WAT in animals and humans (Giralt & Villarroya, 2013; Lo & 
Sun, 2013; Rosenwald & Wolfrum, 2014). When exposed to cold temperature, hormonal 
stimuli (e.g. irisin and T3) (Obregon, 2014a; Zhang et al., 2014), or pharmacological 
treatment (e.g. rosiglitazone, bone morphogenetic protein, and isoproterenol) (Elsen et 
al., 2014; Obregon, 2014b; J. Wu et al., 2012), beige adipocytes can adopt a brown 
adipocyte phenotype (i.e., browning) with increased UCP-1 expression, contributing to 
thermogenesis and energy expenditure. Identification and characterization of dietary 
bioactive components to increase the development and functions of both classical 
brown and beige adipocytes hold great promise for obesity treatment and prevention.  
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Therefore, this dissertation begins with an overview of the role of inflammation, 
functions of adipose tissue, and genetic, pharmacological, and nutritional regulators for 
BAT development and browning functions. The chapter II focuses on the role of acute 
PRR activation in inflammation and mitochondrial respiration in mature brown 
adipocytes. The chapter III focuses on the role of chronic PPR activation in brown 
adipogenesis using two brown adipogenesis cellular models: immortalized brown pre-
adipocytes and multipotent mesodermal stem cells. The chapter IV reports the effects of 









1.1 Obesity and adipose tissue 
1.1.1 Obesity and metabolic disease 
Obesity has become a growing epidemic worldwide over the past few decades 
(Keating, Backholer, & Peeters, 2014; Ng et al., 2014; Seidell & Halberstadt, 2015). 
Currently, almost 70% of adults in the US are overweight and 25% are obese, with rates 
having almost tripled in the last two decades (Ezzati, Martin, Skjold, Vander Hoorn, & 
Murray, 2006). Obesity is caused by a positive energy balance when energy intake 
exceeds energy expenditure over a given period of time (Vandevijvere, Chow, Hall, 
Umali, & Swinburn, 2015). Food intake is a major source of energy intake, while 
physical activity and basic metabolism rate are the major contributors to energy 
expenditure (Church et al., 2011; Hill, Wyatt, & Peters, 2012). However, our 
understanding of the mechanisms by which the body acts to achieve and maintain 
energy balance is incomplete (Hill et al., 2012).  
In humans, energy is spent in several forms. Energy is expended to support 
basal metabolism needs for the normal functioning of cells and organs at rest. It is also 
expended to absorb and metabolize consumed food, which is referring to the thermic 
effect of food. Energy is also consumed through physical activity (Hill et al., 2012; 
Joosen & Westerterp, 2006) and dissipated for adaptive thermogenesis in response to 
environmental changes, such as cold temperature and diet (Tseng, Cypess, & Kahn, 
2010). There are three types of thermogenesis: shivering thermogenesis, non-shivering, 
and diet-induced heat dissipation (Cannon & Nedergaard, 2011; Tseng et al., 2010). 
Shivering thermogenesis is induced in skeletal muscles and is a process in which heat 
is generated by shivering to stay warm (Tseng et al., 2010; van den Berg, van Marken 
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Lichtenbelt, van Dijk, & Schrauwen, 2011). Non-shivering thermogenesis occurs in the 
brown adipose tissue (BAT) upon certain stimuli such as cold exposure (Mineo, Cassell, 
Roberts, & Schaeffer, 2012; Nguyen et al., 2011; Sammons & Price, 2014; Teulier et al., 
2010; van der Lans et al., 2013; van Marken Lichtenbelt & Schrauwen, 2011), while 
overfeeding could trigger the diet-induced thermogenesis propensity of brown fat to 
achieve energy balance (Shingo Kajimura & Saito, 2014; Tseng et al., 2010).  
Obesity is a well-known risk factor that leads to metabolic disorder, including 
diabetes (Shigetoh et al., 2009), hypertension (Re, 2009), cardiovascular diseases 
(Apovian & Gokce, 2012), and cancers (Basen-Engquist & Chang, 2011). Metabolic 
disorder has at least three of the following features: abdominal obesity (waist 
circumference > 40 inches in males or 35 inches in females), hypertriglyceridemia (≥ 
150 mg/dL), low HDL cholesterol (< 40 mg/dL in men or < 50 mg/dL in women), 
hypertension (≥ 130/85 or on antihypertensive medication), or elevated fasting glucose 
(≥ 110 mg/dL or on medication for diabetes). Insulin resistance has been suggested as 
the primary factor responsible and precedes other aspects of metabolic disorder 
(National Institutes of Health, 2011).     
1.1.2 Anatomy of adipose tissue: WAT and BAT 
There are two major types of adipose tissue: white adipose tissue (WAT) and 
BAT, which contribute to energy balance in humans (Y. H. Lee, Mottillo, & Granneman, 
2014). WAT exists throughout the body and has different functions depending on the 
anatomical site. WAT is mainly found in two places: visceral adipose tissue and 
subcutaneous adipose tissue. Visceral adipose tissue is predominantly located around 
the inner organs, such as the intestines, stomach, spleen, kidney, gonad, uterus, 
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ovaries, epididymis, testis, and pericardial. Subcutaneous adipose tissue is located 
around the abdomen, hips, thighs, legs, and other lower body parts. The function of 
subcutaneous adipose tissue is protecting organs in the body and lipid accumulation 
(Bjørndal, Burri, Staalesen, Skorve, & Berge, 2011; Gesta, Tseng, & Kahn, 2007). 
Visceral adipose tissue is more associated with metabolic issues such as insulin 
resistance than subcutaneous adipose tissue.  In contrast, BAT exists in a distinct 
location depending on species (only higher mammals) and age (Gesta et al., 2007; 
Saely, Geiger, & Drexel, 2012). 
BAT is most abundant in the interscapular region and is present throughout life in 
rodents. In humans, BAT is located in the interscapular region and found in the cervical, 
paravertebral, supraclavicular, periadrenal, suprarenal, and subscapular areas in 
infants. However, it is remarkably reduced with age, leading to a remarkable absence in 
adults (Cinti, 2001, 2007; Gesta et al., 2007; Lanthier & Leclercq, 2014; Y. H. Lee et al., 
2014; Saely et al., 2012; Vosselman, van Marken Lichtenbelt, & Schrauwen, 2013). 
Infants do not have enough muscles for shivering when exposed to cold temperatures, 
making heat production from BAT essential for maintaining temperature homeostasis 
(Devlin, 2015; Hu, Yin, et al., 2013; Zafrir, 2013). However, recent studies have 
detected BAT in adults using 2-deoxy-2-(18F)fluoro-D-glucose integrated with Positron 
Emission Tomography associated with Computed Tomography (18F-FDG PET/CT). 
FDG is the most common radiotracer and makes fluorine attach to glucose. Intravenous 
FDG and PET/CT scan images identify BAT spots through the anatomic localization of 
radiotracer uptake (Holstila et al., 2013; Hu, Perkins, Chia, & Gilsanz, 2013; J. W. Park 
et al., 2015).  
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The amount of active BAT in adult humans is associated with temperature, 
stress, age, and obesity (Cereijo, Giralt, & Villarroya, 2015; De Matteis et al., 2013; 
Saely et al., 2012; Virtanen, van Marken Lichtenbelt, & Nuutila, 2013; Vosselman et al., 
2013; Zafrir, 2013). Catecholamine secreted in response to stress is also correlated with 
BAT activity. Pheochromocytoma patients have six times higher plasma metanephrine 
than normal patients and more BAT measured by 18F-FDG PET/CT, while their body 
weight, cholesterol, blood glucose, triglyceride, and WAT show no significant difference 
(Q. Wang et al., 2011). BAT is more activated when exposed to cold temperature (16°C) 
compared to warm temperature (22°C) in lean male adults (body mass index (BMI) of 
23 or lower). In addition, more BAT is detected in lean male adults in PET/CT scan 
images than obese adult males when exposed to cold temperature (van Marken 
Lichtenbelt et al., 2009). This also extends to in vivo studies that show lean mice have 
more BAT in 18F-FDG PET images than obese imprinting control region (ICR) mice fed 
a high-fat diet (70% fat) and streptozocin-induced diabetic mice (C. Wu et al., 2014).  
1.1.3 Functions of adipose tissue: WAT and BAT 
The main functions of WAT are lipid synthesis and energy storage (Pavelka, 
Roth, Pavelka, & Roth, 2010). Excess energy in the form of triglycerides stored in WAT 
is hydrolyzed to free fatty acids and then released into the body’s circulation to be used 
as energy for the organs (Giralt & Villarroya, 2013; Saely et al., 2012). This process of 
lipolysis plays important roles in energy metabolism, such as energy homeostasis in the 
human body. Besides energy storage and release, WAT also acts as an important 
endocrine organ as it expresses and secretes several polypeptide hormones known as 
adipokines, including leptin and adiponectin (Trayhurn & Beattle, 2001). 
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Increased serum leptin levels and decreased serum adiponectin levels are 
associated with higher obesity rates (Ricci & Bevilacqua, 2012). A higher ratio of leptin 
to adiponectin is observed in Italian young adults with severe obesity and metabolic 
phenotypes (insulin resistance and higher plasma lipid levels) than normal obese Italian 
young adults (Labruna et al., 2011). Leptin was first identified as an adipocyte hormone 
and plays an important role in controlling appetite, leading to the regulation of energy 
homeostasis in the body (Siegrist-Kaiser et al., 1997). Serum leptin level and body 
weight are increased in C57BL/6 mice fed a high-fat diet (60% fat) compared to regular 
chow-fed lean mice (Rhodes et al., 2013). Leptin (10 nM) significantly increases glycerol 
release, leading to lipolysis, in the WAT fat pad of Sprague-Dawley rats (Siegrist-Kaiser 
et al., 1997). Leptin-deficient ob/ob mice (C57BL/6J) have higher body weight and blood 
glucose level than lean mice (C57BL/6) (Drel et al., 2006). Acute physiological leptin 
(50-200 ng/h implanted tube by surgery) in leptin-deficient ob/ob mice dose-dependently 
reduces body weight and significantly increases plasma leptin level (Morton et al., 
2011). Adiponectin, known as adipoQ, is also a key regulator of energy metabolism 
(Bjursell et al., 2007; Fang & Sweeney, 2006; Lafontan & Viguerie, 2006). Adiponectin 
is responsible for insulin sensitivity (Kadowaki et al., 2006; Maeda et al., 2002) and fatty 
acid oxidation (Yamauchi et al., 2002; Yoon et al., 2006). The levels of adiponectin and 
insulin resistance are significantly decreased in humans with obesity (Abdelgadir, 
Karlsson, Berglund, & Berne, 2013; Yadav, Kataria, Saini, & Yadav, 2013). Adiponectin 
macrophage-specific transgenic mice encoding human adiponectin gene and fed a 
high-fat diet have less tumor necrosis factor (TNF)-α and monocyte chemotactic protein 
(MCP)-1 mRNA expression in macrophage, skeletal muscle, and adipose tissue. In 
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addition, glucose tolerance and insulin tolerance are decreased in transgenic mice fed a 
high-fat diet compared to lean mice (Luo et al., 2010). 
In contrast, the key function of BAT is to promote energy expenditure (Y. H. Lee 
et al., 2014). BAT is primarily responsible for energy oxidation to produce heat via 
uncoupling respiration to maintain the body’s temperature (McMillan & White, 2015; 
Saely et al., 2012; van Marken Lichtenbelt & Schrauwen, 2011; Virtanen et al., 2013). In 
WAT, once the sympathetic nervous system (SNS) is activated, a neurotransmitter such 
as noradrenaline is released. The neurotransmitter then binds to beta-adrenergic 
receptors (β-AR) on the plasma membrane of adipocytes, leading to adenylyl cyclase 
activation. This in turn promotes the conversion of adenosine triphosphate (ATP) into 
the second messenger cyclic adenosine monophosphate (cyclic AMP or cAMP), 
activates protein kinase A (PKA), and subsequently releases free fatty acid through the 
lipolysis process. Free fatty acid released from lipid droplets is oxidized through the 
Krebs cycle in the mitochondria, and the intermediated electrons from the Krebs cycle 
flow through the electron transport chain (ETC) and produce a proton gradient to 
generate energy through ATP synthesis (Azzu & Brand, 2010; Brondani et al., 2012). In 
BAT, however, proton leak is produced from uncoupling protein-1 (UCP-1) on the 
mitochondrial inner membrane to generate heat instead of cellular respiration ATP 
synthesis (Azzu & Brand, 2010; Brondani et al., 2012; Cohen & Spiegelman, 2015; 
Harms & Seale, 2013). Saturated purine nucleotides (GDP) inhibit UCP-1 activation and 
fatty acids (palmitate) reactivate UCP-1. Heat generation via UCP-1 protein in BAT 
uncouples the respiratory chain, allowing fatty acid to be oxidized with low ATP 
production. The function of UCP-1 in BAT is discussed further in a later section. 
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Understanding the physiological and pathological mechanisms for reducing WAT 
functions and developing BAT functions can be important for preventing obesity. The 
key regulators of BAT development are discussed in a later section.   
1.2 Chronic inflammation in obesity 
1.2.1 Adipose inflammation in obesity 
Inflammation in adipose tissue has been generally recognized as a primary 
cause of obesity and obesity-associated diseases (Balistreri, Caruso, & Candore, 2010). 
Adipose tissue comprises many kinds of cell types, including adipocytes, vascular cells, 
fibroblasts, and macrophages (Eto et al., 2009). Research has detected the infiltration of 
macrophages in adipose tissue of obese mice (Nishimura, Manabe, Nagasaki, et al., 
2009). Infiltration of F4/80+ cluster of differentiation (CD)11b+ macrophages has also 
been demonstrated to be significantly higher in obese C57BL/6J mice fed a high-fat diet 
high fat diet and leptin-deficient ob/ob mice compared to regular chow-fed counterparts 
(Nishimura, Manabe, Nagasaki, et al., 2009). Macrophages in adipose tissue are 
responsible for inflammatory-specific gene expression, such as interleukin (IL)-6, TNF-
α, transforming growth factor (TGF)-β, MCP-1, and chemotactic cytokine ligand 5 (CCL5 
or RANTES) (Balistreri et al., 2010; Braunersreuther, Viviani, Mach, & Montecucco, 
2012; Fantuzzi, 2005; Gilbert & Slingerland, 2013). Mice intraperitoneally injected with 
serum free macrophage-derived condition medium (0.1 mL/10 g) have significantly 
higher mRNA expression of TNF-α, IL-6, and MCP-1 in adipose tissue compared to 
saline-injected mice (Jiang et al., 2014). Ponies with metabolic diseases have 10-fold 
higher resting insulin level, serum TNF-α and IL-6 concentration, and body weight with 
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increased macrophage infiltration and TNF-α and IL-6 expression in adipose tissue 
compared to healthy ponies (Basinska, Marycz, Śmieszek, & Nicpoń, 2015). 
TNF-α is secreted from adipocytes through activation of the mitogen-activated 
protein kinase (MAPK) and nuclear factor kappa B (NF-κB) signaling pathways, leading 
to the enhanced expression of inflammatory-related genes (X. Chen, Xun, Chen, & 
Wang, 2009; Gountopoulou, Leondaritis, Galanopoulou, & Mavri-Vavayanni, 2008). 
TNF-α is an especially important factor for adipose tissue because it regulates insulin 
resistance through insulin receptor signaling, and its upregulation leads to obesity and 
diabetes. A clinical study has indicated that serum TNF-α is upregulated in 
overweight/obese humans (13 males and 15 females with BMI of 27 or more) compared 
to lean humans (7 males and 8 females with BMI of 25 or less). In addition, expression 
of TNF-α in both subcutaneous and visceral adipose tissues is significantly increased (3 
folds) in obese humans compared to lean humans (Winkler et al., 2003). TNF-α-infused 
male Syrian golden hamsters (0.5 μg/kg/h for 4 hours) have lower phosphorylation of 
insulin receptor (IR)-β and IR substrate-1 (IRS-1) in primary hepatocytes compared to 
control hamsters (Qin, Anderson, & Adeli, 2008), indicating TNF-α-induced hepatic 
insulin resistance.  
As with TNF-α, IL-6 also plays an important role in inflammation in adipose tissue 
(Carlsen et al., 2009; Eder, Baffy, Falus, & Fulop, 2009). It has been shown that higher 
adiposity, body fat mass, waist circumference, and fatty acid levels increase serum IL-6 
level in human studies (Morisset, Huot, Légaré, & Tchernof, 2008; Rexrode, Pradhan, 
Manson, Buring, & Ridker, 2003). Women (773 aged 50s) who have higher weight, BMI, 
body fat mass, and abdominal adipose tissue have higher circulating IL-6 level 
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(Morisset et al., 2008). A randomized double-blind study has also shown that higher 
serum IL-6 levels are detected in women who have higher BMI and waist/hip ratio 
among a total of 48 women (aged 39.6-61.7 and BMI of 17.2-41.3) (Rexrode et al., 
2003).  
MCP-1, a chemotactic factor, is significantly enhanced in the plasma of obese 
mice and humans (C. Kim et al., 2006; Takahashi et al., 2003). MCP-1 expression in 
epididymal WAT and circulating MCP-1 protein level are remarkably increased in 
C57BL/6N mice fed a high-fat diet (32.6% fat for 6 months) compared to regular chow-
fed mice (Takahashi et al., 2003). A clinical study by Kim and associates has 
demonstrated that obese subjects (BMI of 30 or above) have higher triglyceride, total 
cholesterol, MCP-1, and IL-6 in serum compared to non-obese counterparts (BMI of 20 
or less) (C. Kim et al., 2006). The expression of MCP-1 mRNA in WAT and plasma 
MCP-1 levels are significantly increased in C57BL/6J obese mice fed a high-fat diet, but 
not increased in regular chow-fed mice (Kanda et al., 2006). In addition, macrophage 
infiltration and expression of macrophage-related genes, TNF-α, CD68, and F4/80, are 
reduced in adipose tissue of MCP-1 knockout C57BL/6J mice (Kanda et al., 2006).  
Evidence of the relationship between adipose tissue inflammation and obesity 
has been shown in animal and human studies (Nishimura, Manabe, & Nagai, 2009; 
Vieira et al., 2009; Wentworth et al., 2010). Humans with obesity or with both obesity 
and metabolic diseases have more macrophage infiltration in subcutaneous adipose 
tissue compared to lean humans. More macrophage infiltration leads to higher 
expression of proinflammatory cytokines, IL-1β, IL-6, and TNF-α (Wentworth et al., 
2010). Furthermore, abnormal adipose function and lipid metabolism in obesity lead to 
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inflammation in adipose tissue (Ichimura et al., 2012; Iyer, Fairlie, Prins, Hammock, & 
Brown, 2010; Lumeng & Saltiel, 2011). High-fat diet-fed G-protein coupled receptor 
(GPR)120 knockout mice have 10% increased body weight compared to high-fat diet-
fed wild-type mice. Lacking of GPR120 also leads to insulin resistance, resulting in 
decreased insulin signaling and increased inflammation in adipose tissue. High-fat diet-
fed GPR120 knockout mice show impaired glucose metabolism, which is revealed by 
increased levels of fasting glucose and blood glucose. Moreover, adipocyte size and 
macrophage marker genes, CD11b, CD68 and F4/80, in adipose tissue are increased in 
high-fat diet-fed GPR120 knockout mice (Ichimura et al., 2012). 
1.2.2 Role of the pattern recognition receptor in adipose inflammation 
Lumeng has reviewed the importance of the innate immune response in obesity 
(Lumeng, 2013). Adipocytes attacked by foreign microbes recruit inflammatory 
macrophages around the damage site of the adipocytes, which secrete inflammatory 
cytokine, resulting in insulin resistance (Lumeng, 2013). The innate immune system 
recognizes pathogen-associated molecular patterns (PAMPs) via pattern recognition 
receptors (PRRs) that play an important role in inflammation and immune response 
(Miller et al., 2011; Takeuchi & Akira, 2010; Tang et al., 2011). There are two families of 
PPRs: membrane-bound toll-like receptors (TLRs) and cytoplasmic nucleotide 
oligomerization domain-like receptors (NLRs) in response to the inflammation of 
adipose tissue (J. Y. Lee, Zhao, & Hwang, 2010; Watanabe, Nagai, & Takatsu, 2013).  
TLRs are composed of the extracellular leucine-rich repeat (LRR) and the 
cytoplasmic toll/interleukin-1 receptor (TIR) domain. There are 10 TLRs identified in 
humans, and each TLR recognizes a different ligand. For example, TLR2 and TLR4 
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recognize lipoprotein and lipopolysaccharide (LPS), respectively (Barton & Medzhitov, 
2002; S.-J. Kim, Choi, Choi, & Park, 2012; Takeuchi & Akira, 2010). It has been widely 
shown that TLR2 and TLR4 are involved in metabolic functions and the inflammatory 
response in obesity (Ahmad et al., 2012; Fusaru et al., 2012). Immunohistochemical 
reaction results have shown that in lean subjects, TLR2 and TLR4 are expressed only in 
CD68 positive immunocompetent cells (which could be lymphocytes and myeloblasts). 
However, in obese subjects with BMI of 30 and over, TLRs 2 and 4 are expressed in 
three cell types: immunocompetent cells, vessels, and adipose cells. Subjects with 
diabesity (obesity and diabetes) have higher TLR2 and TLR4 expression in all three 
types of cells than obese subjects (Fusaru et al., 2012). The activation of TLR2 and 
TLR4 is mediated by MyD88, which comprises the death domain and TIR domain. 
Ahmad et al. have shown that TLR2 and TLR4 mRNA expression in peripheral blood 
mononuclear cells is positively correlated with BMI in human subjects 
(obese>overweight>lean). TLR2 and TLR4 expression in adipose tissue also increases 
in obese subjects (also obese>overweight>lean) (Ahmad et al., 2012).  
MyD88 is more highly expressed in peripheral blood mononuclear cells and the 
adipose tissue of obese subjects than in lean subjects (Ahmad et al., 2012). MyD88 
activates the MAPK and NF-κB pathways that are responsible for inflammatory 
response (Kawai & Akira, 2007). LPS (0.25-5 μg/mL for 12-48 hours) increases 
expression of TLR4 and proinflammatory cytokines, IL-6 and TNF-α, in primary bone 
marrow mesenchymal stem cells isolated from C57BL/6J mice (R.-L. Huang et al., 
2013). Phosphorylation of NF-κB p65 and NF-κB are significantly increased in the LPS-
treated bone marrow mesenchymal stem cells of wild type mice (C57BL/10 and 
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C57BL/6J), but are reduced in TLR4 knockout mice (C57BL/10ScNJ) and MyD88 
knockout mice (R.-L. Huang et al., 2013). Fatty acid induces inflammatory response 
through TLR4 in adipose tissue in obese mice (Jung & Choi, 2014; Shi et al., 2006; 
Song, Kim, Yoon, & Kim, 2006). Free fatty acid induces TNF-α mRNA and IL-6 
expression in macrophages and adipocytes isolated from wild-type mice but not in 
macrophages isolated from TLR4 knockout mice (C57BL6/J strain). Obese C57BL6/J 
mice fed a high fat diet (D12331 from Research Diets Inc. for 16 weeks) and leptin-
deficient ob/ob mice have higher TLR4 mRNA expression in adipose tissue than regular 
chow-fed control mice and wild-type mice, respectively (Shi et al., 2006). 3T3-L1 
adipocytes treated with free fatty acid (750 μM for 3 hours), LPS (5 μg/mL for 1 hour), 
and TNF-α (5 ng/mL for 1 hour) increase NF-κB activities by 2, 2, and 4-fold, 
respectively (Song et al., 2006). Male TLR4 knockout mice fed a high-fat diet (45% fat) 
have less body weight, subcutaneous adipose tissue, and visceral adipose tissue than 
C57BL/6J wild-type mice (Pierre et al., 2013). Both TLR4 and TLR2 mRNA are highly 
expressed in mature 3T3-L1 adipocytes and adipose tissue of high-fat diet-fed 
C57BL/6J mice and leptin-deficient ob/ob mice (Purohit et al., 2013; Zhao, Hu, Zhou, 
Purohit, & Hwang, 2011). Furthermore, TLR2 is responsible for insulin resistance in 
adipocytes. A previous study has shown that expression of IL-6, MCP-1, TLR2, and 
TLR4 is increased in 3T3-L1 adipocytes treated either palmitate (0.5 mM) or LPS (10 
μg/mL) compared to non-treated cells. 3T3-L1 adipocytes treated with palmitate and 
LPS for 48 hours reduce insulin-stimulated 2-deoxyglucose uptake compared to non-
treated control cells. Palmitate and LPS also increase NF-κB activation and IL-6, MCP-
1, TLR2, and TLR4 mRNA expression through JNK pathways in 3T3-L1 adipocytes 
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(Davis, Gabler, Walker-Daniels, & Spurlock, 2009). Unlike TLR4 knockout mice, TLR2 
knockout mice (C57BL/6J strain) are heavier than wild-type mice. MyD88 and IRS-1 
expression is also increased, but insulin sensitivity is decreased in the muscle, liver, and 
adipose tissue of TLR2 knockout mice compared to wild-type mice (Caricilli et al., 
2011). On the other hand, Ehses has reported that female TLR2 knockout mice 
(C57BL/6J strain) fed a high-fat diet for 20 weeks have improved peripheral insulin 
sensitivity than wild-type mice fed a high fat diet, indicating that the lack of TLR2 may 
lead to metabolic phenotype. Female TLR2 knockout mice fed a high-fat diet have less 
fat weight and MCP-1 mRNA expression in the liver, with no changes of other 
inflammatory cytokines in the liver, including IL-6 and TNF-α (Ehses et al., 2010). This 
suggests that mice without TLR2 may be protected from insulin resistance when fed a 
high fat diet. The different results from Caricilli and Ehses may be explained by the 
gender difference (male vs. female) or diet (regular chow vs. high-fat diet).  
The NLR family is composed of the central nucleotide binding domain and the C-
terminal LRR domain. There are two prominent members in the NLR family: nucleotide 
binding oligomerization domain (NOD)1 and NOD2. NOD1 recognizes γ-D-glutamyl-
meso-diaminopimelic acid (iE-DAP, found in the peptidoglycan of gram-negative 
bacteria), and NOD2 recognizes MurNAc-L-Ala-D-isoGln (MDP, found in all bacteria) in 
the cytoplasm (Takeuchi & Akira, 2010). It has been shown that activated NOD1 and 
NOD2 intermediate inflammation in the adipocytes and adipose tissue of high-fat diet-
induced obese mice and obese humans (Zhao et al., 2011; Zhou, Zhou, Li, & Song, 
2012). NOD1 and NOD2 mRNA expression is positively correlated with the 
differentiation rate of primary adipocytes isolated from the subcutaneous abdominal 
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WAT of obese women. Primary human adipocytes treated with NOD1 ligand (iE-DAP, 
100 μg/mL) induce NF-κB expression as well as IL-6, IL-8, and MCP-1 production, but 
no change is observed in primary human adipocytes treated with MDP (10 μg/mL) 
(Zhou et al., 2012).  
Similar to TLRs, NLRs are also responsible for inflammatory reactions through 
the activation of MAPK and NF-κB pathways, leading to the production of 
proinflammatory cytokines. Studies have shown that mRNA expression of NOD1 and 
NOD2 is significantly increased in mature murine adipocytes, and NOD1, but not NOD2, 
is highly expressed in epididymal and subcutaneous adipose tissue of high-fat diet (60% 
fat for 20 weeks)-induced obese mice (C57BL/6J) (Zhao et al., 2011).  MCP-1, CCL5, 
TNF-α, and IL-6 expression through the MAPK/NF-κB pathway is significantly increased 
in NOD1 ligand Tri-DAP (10-50 μg/mL for 15 hours)-induced 3T3-L1 adipocytes (Zhao 
et al., 2011). NOD1/2 double knockout male mice (C57BL/6 strain) fed a high-fat diet for 
16 weeks have less adipose tissue, decreased liver weight, and reduced blood glucose 
level in insulin-tolerance compared to wild-type male C57BL/6 mice. NOD1 activation by 
NOD1 ligand FK156 (100 μg) induces insulin intolerance in NOD1 knockout mice, which 
is revealed by no change in blood glucose level. However, the glucose level is 
increased in wild-type and NOD2 knockout mice (Schertzer et al., 2011). On the other 
hand, NOD2 activation by NOD2 ligand MDP (5-10 μg/mL) significantly decreases 2-
deoxyglucose uptake in L6-GLUT4 muscle cells. Phosphorylation of MAPK and IRS-1 




Inflammation in adipose tissue, a hallmark of obesity, interferes with insulin 
resistance in WAT and energy expenditure in BAT, potentially leading to adipose tissue 
dysfunction. Inflammation also inhibits white and brown adipocyte differentiation, which 
disrupts energy storage in WAT and reduces BAT activation. Therefore, better 
understanding of the adipose tissue inflammation mechanism can help in the prevention 
of adipose dysfunction.  
1.3 Novel targets for obesity treatment and prevention: Brown and 
beige adipocytes 
1.3.1 Browning and beige 
The main cells in both types of adipose tissue are called adipocytes (Rosenwald 
& Wolfrum, 2014). Interscapular BAT contains classic brown adipocytes, whereas 
epididymal and subcutaneous adipose tissues contain classic white adipocytes 
(Sanchez-Gurmaches & Guertin, 2014). White adipocytes have a single lipid droplet 
consisting of triglycerides and a small number of mitochondria. In contrast, brown 
adipocytes have multiple small lipid droplets and enriched amounts of mitochondria that 
are closer to those of skeletal muscle cells rather than white adipocytes (Algire, 
Medrikova, & Herzig, 2013; Giralt & Villarroya, 2013; Nakagami, 2013; A. Park, Kim, & 
Bae, 2014; Rosenwald & Wolfrum, 2014). Besides white and brown adipocytes, a third 
type has recently been discovered called beige adipocytes (Beranger et al., 2013; Giralt 
& Villarroya, 2013), which is identified in WAT. They differ in that they have few 
mitochondria and lower UCP-1 expression without stimuli. However, upon activation by 
exposure to physiological, pharmacological, or hormonal stimuli, the cells demonstrate 
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BAT-like phenotype with increased number of mitochondria, UCP-1 expression, and 
cellular respiration, a process referred to as the “browning” of WAT (Barneda, Frontini, 
Cinti, & Christian, 2013; Bartelt & Heeren, 2014; Bi & Li, 2013; Bonet, Oliver, & Palou, 
2013; Elsen, Raschke, & Eckel, 2014; Giralt & Villarroya, 2013). Although certain cells 
in WAT show the BAT phenotype, the cells are not exactly the same as the classic 
brown fat cells, which is why the brown-like cells located in WAT have been called 
“beige” or “brite (brown in white)” cells (Harms & Seale, 2013; Keipert & Jastroch, 2014; 
P. Lee, Werner, Kebebew, & Celi, 2014; McMillan & White, 2015; A. Park et al., 2014; J. 
Wu et al., 2012; J. Wu, Cohen, & Spiegelman, 2013).  
Human beige cells have been detected in PET/CT scan images in the neck and 
chest upon cold exposure (Bartelt & Heeren, 2014; J. W. Park et al., 2015). The number 
of white adipocytes in WAT is decreased while BAT is increased when adult female 
Sv129 mice are exposed to cold temperature for 10 days (Cinti, 2009). Obese patients 
have fewer beige cells compared to lean patients (Fernández-Galilea et al., 2015; P. 
Lee et al., 2014; Vijgen et al., 2011). Beige cells have also been detected in the WAT 
deposits of lean rodents but not in obese rodents (Rachid et al., 2015; J. Wu et al., 
2012). Carey and colleagues have detected UCP-1 expression in differentiated primary 
white adipocytes isolated from the abdominal subcutaneous adipose tissue of healthy 
young adults but not in that of obese young adults (Carey et al., 2014). Expression of 
genes representing general adipogenesis, browning, and beige adipogenesis is higher 
in differentiated primary adipocytes than precursor cells (Carey et al., 2014). Although 
genes for classic brown adipogenesis have not been sufficiently detected, precursor 
cells in WAT have the potential to become brown-like adipocytes or beige adipocytes 
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since genes related to browning and beige adipogenesis are highly expressed in the 
primary adipocytes of WAT.  
After beige cells are discovered, transdifferentiation, which is the transformation 
of white cells into brown-like cells, has been used for research on preventing obesity. 
Although white fat cells and brown fat cells have different characteristics, functions, and 
morphology, they share pluripotent mesenchymal stem cell as a common precursor. 
Hence, pluripotent mesenchymal stem cells are widely used for the browning process in 
in vitro studies (Algire et al., 2013; Birerdinc, Jarrar, Stotish, Randhawa, & Baranova, 
2013; Giralt & Villarroya, 2013; Nakagami, 2013; A. Park et al., 2014; Rosenwald & 
Wolfrum, 2014). The regulators of the browning process are discussed in more detail in 
a later section.  
1.3.2 Origins of brown and beige adipocytes 
The difference of preadipocytes among brown adipocytes, white adipocytes, and 
beige adipocytes is the expression of myogenic regulatory factor (Myf)5, which is 
essential for skeletal muscle function (Ott, Bober, Lyons, Arnold, & Buckingham, 1991). 
Reduced muscle mass and delayed skeletal muscle regeneration are observed in Myf5 
knockout mice (129Sv/C57BL/6 background) compared to wild-type mice (Ustanina, 
Carvajal, Rigby, & Braun, 2007). BAT contains 95% Myf5-positive and 5% Myf5-
negative preadipocytes, while subcutaneous WAT contains 49% Myf5-positive and 51% 
Myf5-negative cells, and visceral WAT contains 70% Myf5-positive and 30% Myf5-
negative preadipocytes (Sanchez-Gurmaches & Guertin, 2014). Brown adipocytes 
derived are exclusively from Myf5-positive myogenic lineages that can also be muscle 
cells, while white adipocytes are derived from Myf5-negative adipogenic lineages 
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(Sanchez-Gurmaches & Guertin, 2014). Beige adipocytes, however, have not been 
clearly defined. Reviewers have suggested that beige adipocytes can be derived from 
both Myf5-positive and -negative lineages, which exist in BAT and WAT, respectively 
(Gilsanz, Hu, & Kajimura, 2012; Giralt & Villarroya, 2013). Hence, the Myf5 expression 
of beige adipocytes is still questionable. In addition, the origin of beige adipocytes is 
reversible in that beige adipocytes are derived from either white adipocyte precursor 
cells or are converted from mature white adipocytes (Cinti, 2009; Q. A. Wang, Tao, 
Gupta, & Scherer, 2013; J. Wu et al., 2012).  
There are several phases in between pluripotent mesenchymal stem cells and 
mature adipocytes, including the commitment and differentiation phases (Rosen & 
MacDougald, 2006). Key regulators covert the pluripotent mesenchymal stem cells to 
undifferentiated pre-cells such as osteoblasts, preadipocytes, and myoblasts (DiMarino, 
Caplan, & Bonfield, 2013). When stem cells complete the commitment phase, the pre-
cells are differentiated by the regulation of specific transcriptional factors and become 
bone cells, fat cells, or muscle cells with their specific properties (Alonso, Claros, 
Becerra, & Andrades, 2008; Andrades et al., 2011; DiMarino et al., 2013).  
1.3.3 Regulation of BAT development and function 
Adipogenesis is a multi-step process, that includes growth arrest, clonal 
expansion, and differentiation from preadipocytes to become mature adipocytes 
(Carobbio, Rosen, & Vidal-Puig, 2013). Murine 3T3-L1 and 3T3-F442A white 
preadipocytes are widely used in white adipogenesis studies, and immortalized brown 
fat cell lines are available for brown adipogenesis studies (Moreno-Navarrete & 
Fernández-Real, 2012). Furthermore, transgenic mice models are used for studies 
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regarding adipose tissue function and development. A review paper (Harms & Seale, 
2013) published in 2013 indicates enhanced beige fat activity in five types of transgenic 
mouse models with overexpression of prostaglandin-endoperoxide synthase (PTGS)2, 
forkhead box protein c (Foxc)2, PR domain containing (PRDM)16, phosphatase and 
tensin homolog (Pten), and UCP-1. Several transcriptional factors have been identified 
as regulating adipogenesis and adipose tissue development (Siersbæ k, Nielsen, & 
Mandrup, 2012). Many studies on WAT and white adipocytes have already been 
conducted for the prevention of obesity, from benchside to human studies (Cummins et 
al., 2014; E. Y. Kim et al., 2015; Vázquez-Vela, Torres, & Tovar, 2008). Over the past 
decade, however, there has been increasing interest in the function and development of 
BAT and brown adipocytes for obesity prevention (Beranger et al., 2013; Bi & Li, 2013; 
Elattar & Satyanarayana, 2015; Harms & Seale, 2013; Lo & Sun, 2013; Saely et al., 
2012; Seale, Kajimura, & Spiegelman, 2009; Virtanen et al., 2013; Vosselman et al., 
2013; Whittle, Relat-Pardo, & Vidal-Puig, 2013). Therefore, in this section discusses 
three key regulators for BAT function and development: UCP-1, PGC1α, and PPARγ. 
UCP-1 is a key brown marker gene for adaptive non-shivering thermogenesis in 
BAT (Cypess et al., 2009; Kozak, Koza, & Anunciado-Koza, 2010; Richard & Picard, 
2011). UCP-1 is located in the inner mitochondrial membrane and produces heat in the 
ETC (Symonds, 2013). The expression of UCP-1 is regulated by several factors, 
including chronic cold exposure (van der Lans et al., 2013), activated hormone 
receptors (Martinez de Mena, Scanlan, & Obregon, 2010), the activation of the SNS 
(Mottillo et al., 2014), and other transcriptional factors (Symonds, 2013). Mice exposed 
to cold temperature have a greater UCP-1 expression in BAT than mice exposed to 
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warm temperature (Dong et al., 2013). UCP-1 knockout mice (C57BL/6J strain) have 
more cold-sensitive characteristics and a lesser ability to produce heat than wild-type 
mice (C57BL/6J) (Stier et al., 2014). The UCP-1 mRNA level is much lower in leptin-
deficient obese mice than in wild-type mice (Ricciardi et al., 2014), and UCP-1 knockout 
mice are more likely to become obese when fed a high fat diet (Feldmann, 
Golozoubova, Cannon, & Nedergaard, 2009). In addition, UCP-1 is also regulated by 
the activation of cAMP, the thyroid hormone, and PPAR response elements (Martinez 
de Mena et al., 2010; Sears, MacGinnitie, Kovacs, & Graves, 1996). Mice with a 
reduced triiodothyronine (T3) level have lesser UCP-1 expression and lesser 
thermogenic resistance when exposed to cold temperature (Marrif et al., 2005). 
Moreover, the activation of the β-adrenergic receptor also induces UCP-1 expression 
(Mattsson et al., 2011). The activation of the β-adrenergic receptor activates cAMP and 
PKA activation and then activates downstream pathways, such as p38 MAPK, 
increasing UCP-1 expression (Cao, Medvedev, Daniel, & Collins, 2001; Chernogubova, 
Cannon, & Bengtsson, 2004; Collins, 2011; Hutchinson, Chernogubova, Dallner, 
Cannon, & Bengtsson, 2005). Therefore, UCP-1 is essential for BAT function in 
thermogenesis in a cold environment. 
Peroxisome proliferator-activated receptor (PPAR) coactivator 1α (PGC1α), a 
transcriptional factor, is well known as a coactivator of PPAR (Medina-Gomez, Gray, & 
Vidal-Puig, 2007). PGC1α plays a critical role in tissue-specific sites that have a high 
number of mitochondria (Huss & Kelly, 2005). PGC1α induces hepatic gluconeogenesis 
against fasting, leading to the maintenance of blood glucose homeostasis in the liver 
(Rodgers et al., 2005; Y. Wang et al., 2012). PGC1α also regulates glucose uptake and 
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energy metabolism upon physical activities in the skeletal muscle (Baar et al., 2002; 
Bonen, 2009; Ehrenborg & Krook, 2009; C. Kang & Li Ji, 2012; Y.-X. Wang, 2010). 
Furthermore, it plays a more important role in mitochondria biogenesis in BAT than 
WAT, and it is responsible for the UCP-1 expression leading to heat production 
(Bostrom et al., 2012; H. Y. Chen, Liu, Salter, & Lomax, 2013). Therefore, like UCP-1, 
PGC1α is also significantly induced in cold temperatures and by β-adrenergic 
stimulation (Jan Nedergaard, Bengtsson, & Cannon, 2007). PCG1α expression is 
increased by the activation of cAMP-PKA signaling upon β-adrenergic stimulation (Cao 
et al., 2004; Singh, Simpson, & Bennett, 2015). Previous animal studies have shown 
that PGC1α knockout mice have significantly reduced thermogenic function with the 
exhibition of cold intolerance in response to cold exposure (Lin et al., 2004). In addition, 
PGC1α plays a major role in mitochondria biogenesis and the oxidative pathway in BAT 
with PPARγ and PPARα (Hondares et al., 2011). Overexpression of PGC1α in BAT 
increases the number of mitochondria and thermogenic-associated genes, including 
UCP-1 (Bostrom et al., 2012; Valle, Á lvarez-Barrientos, Arza, Lamas, & Monsalve, 
2005). Therefore, PGC1α is essential for BAT development and UCP-1 expression.  
PPARγ plays a critical role in regulating adipogenesis in adipose tissue, as well 
as in adipocytes (Chawla, Schwarz, Dimaculangan, & Lazar, 1994; Lowell et al., 1999; 
Spiegelman, 1998). Studies have shown that PPARγ is required for BAT development 
(S. Kajimura, Seale, & Spiegelman, 2010; J. Nedergaard, Petrovic, Lindgren, 
Jacobsson, & Cannon, 2005; N. Petrovic et al., 2010), and PPARγ knockout mice 
reduce BAT development and thermogenic function (Jones et al., 2005). The activation 
of PPARγ induced by ligands promotes adipose tissue function and increases 
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adipocytes, leading to the increased expression of lipogenic genes such as fatty acid 
binding protein 4 (FABP4) (Benvenuti et al., 2007; Mallon et al., 2008; Tzeng, Chang, & 
Liu, 2014). Knocking out the PPARγ gene in the adipose tissue of mice leads to loss of 
fat and degeneration of adipose tissue function (Jones et al., 2005; F. Wang, Mullican, 
DiSpirito, Peed, & Lazar, 2013). In vitro, PPARγ is a master regulator of adipocyte 
differentiation from preadipocytes to mature adipocytes, and it increases the adipogenic 
gene expression (Chawla et al., 1994; J. Nedergaard et al., 2005; Spiegelman, 1998). 
Likewise, UCP-1 expression is regulated by PPARγ activation in brown adipocytes. It 
has been shown that rosiglitazone, a PPARγ agonist, induces UCP-1 expression in 
brown adipocytes (Pardo et al., 2011; Natasa Petrovic et al., 2010; Teruel, Hernandez, 
Benito, & Lorenzo, 2003).  
1.3.4 Regulation of the browning process 
As discussed in a previous section, browning is the process of transdifferentiation 
from white adipocytes to brown-like adipocytes or beige adipocytes (Beranger et al., 
2013; Bi & Li, 2013; Cinti, 2009). In vivo, browning of WAT is when WAT takes BAT 
phenotype upon certain stimuli (Barneda et al., 2013; Bi & Li, 2013; Lo & Sun, 2013), 
such as exposure to cold, PPARγ agonist, or β-adrenergic receptor activator, which lead 
to thermogenesis, adipogenesis, and/or mitochondria biogenesis (Mineo et al., 2012; 
Nguyen et al., 2011; Teulier et al., 2010; van der Lans et al., 2013; van Marken 
Lichtenbelt & Schrauwen, 2011). Therefore, brown-specific markers and regulators- i.e. 
UCP-1, PGC1α, PPARγ and several newly discovered regulators- are key regulators for 
the browning process (Lo & Sun, 2013).  
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PRDM16 is major factor for brown adipogenesis in WAT and it works with other 
regulators for BAT development, including UCP-1, PGC1α, and PPARγ (Bartelt & 
Heeren, 2014; Lo & Sun, 2013; Seale et al., 2008). PRDM16 is essential for conversion 
from pluripotent mesenchymal stem cells to brown-like cells (Algire et al., 2013; 
Beranger et al., 2013; J. Wu et al., 2012). It has been shown that PRDM16 has higher 
expression in primary adipocytes isolated from subcutaneous WAT but not visceral 
WAT. UCP-1 expression is also enriched in primary adipocytes. Primary subcutaneous 
adipocytes isolated from PRDM16 knockout C57BL/6 mice significantly reduce total and 
uncoupled respiration compared to wild-type mice (Cohen et al., 2014). The role of 
PRDM16 for browning has also been determined in some animal studies. PRDM16, 
UCP-1, and PGC1α mRNA expression in subcutaneous WAT is reduced in PRDM16 
knockout C57BL/6 mice fed a high-fat diet when the mice are exposed to cold 
temperature (Cohen et al., 2014). In contrast, PRDM16 transgenic mice (C57BL/6 
strain) have greater energy expenditure and increased brown adipose-specific markers, 
UCP-1 and PGC1α mRNA levels in WAT. PRDM16 transgenic mice show reduced body 
weight and blood glucose in response to a high-fat diet (Ohno, Shinoda, Spiegelman, & 
Kajimura, 2012; Seale et al., 2011). 
Bone morphogenetic proteins (BMPs), transforming growth factor beta (TGF-β) 
family, are multi-functional growth factors and are initially discovered to induce bone 
formation. A comprehensive analysis study has shown that five BMPs are commonly 
used for both osteogenic and adipogenic differentiation. It has been confirmed that 
BMP2,4,6,7, and 9 induce osteogenic differentiation and adipogenic differentiation, 
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which is revealed by alkaline phosphatase activity at day 7 and oil red O staining at day 
20, respectively, in C3H10T1/2 mesenchymal stem cell (Q. Kang et al., 2008).  
BMP2, BMP4, and BMP7 are mainly used and involved in adipogenic 
differentiation. BMP2 and BMP4 are responsible for conversion of mesenchymal stem 
cells to white adipocytes, whereas BMP7 is responsible for brown adipogenesis (Tseng 
et al., 2008). Recently, it has been discovered that BMP is an essential factor for 
commitment of mesenchymal stem cells to adipocyte lineage (H. Huang et al., 2009). 
During the commitment phase, mesenchymal stem cells treated with 10 ng/mL of BMP2 
and 4, followed by induction of differentiation media resulted in increased lipid 
accumulation, which is assessed by oil red O staining (H. Huang et al., 2009). BMP7 
(3.3 nM for 8 days) induces differentiation of primary brown preadipocytes derived from 
newborn wild-type mice to adipocytes, but 3T3-L1 preadipocytes are not differentiated 
into adipocytes by BMP7 (Tseng et al., 2008). In addition, gene expression of PPARγ, 
C/EBPα, FABP4, PGC1α, PRDM16, nuclear respiratory factor (NRF)-1, and 
transcription factor A (TFAM) are significantly increased in BMP7-treated brown 
adipocytes (Tseng et al., 2008). BMP7 treatment in the commitment phase also induces 
UCP-1 expression in C3H10T1/2 cells (Tseng et al., 2008). In contrast, Xue has shown 
that C3H10T1/2 cells treated with either BMP4 (20 ng/mL) or 7 (100 ng/mL) during the 
commitment phase significantly induce lipid accumulation and increase brown fat 
specific markers, including UCP-1 and PGC1α expression, as well as mitochondrial 
components (Xue et al., 2014). The same results have been shown in 3T3-L1 
adipocytes (Xue et al., 2014).  
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BMP signaling also plays an important role in browning of WAT. Recently, it has 
been shown that BMP4 also promotes a white-to-brown transition in primary human 
adipose stem cells with the induction of BAT-specific markers, including UCP-1 and 
BAT development regulators, such as PRDM16 (Elsen, Raschke, Tennagels, et al., 
2014; Gustafson et al., 2015). UCP-1, PGC1α, and PRDM16 are increased in BMP4-
treated 3T3-L1 adipocytes (Qian et al., 2013). A large number of multilocular brown 
adipocytes and a small number of unilocular white adipocytes are found in BALB/C 
nude mice injected with stem cells treated with either BMP4 or 7 (Xue et al., 2014). 
BMP is also responsible for thermogenesis to maintain body temperature. It has 
confirmed that newborn BMP receptor (BmprIB) knockout mice (C57BL/6J strain) take 
more time to return to normal temperature after cold exposure compared to wild-type 
newborn mice (11 days vs. 48 hours) (Schulz et al., 2013). 
Irisin, first reported in 2012, is well known as the ‘exercise hormone’, because it 
is produced during exercise and leads to energy expenditure in both mice and humans 
(Bostrom et al., 2012). Also called myokine, irisin was initially discovered in muscle cells 
after exercise. Irisin production from primary human skeletal muscle cells is significantly 
different between healthy adults and diabetic adults, but not obese adults [220].  The 
concentration of irisin is in the same range of that of insulin and leptin in human blood 
(Jedrychowski et al., 2015). Serum irisin levels are higher in exercised B6 mice (12 
weeks) and non-diabetic obese male adults aged 50 days (free wheel running for 3 
weeks and endurance exercise for 10 weeks, respectively). Another study, however, 
has shown that plasma irisin levels after 26 weeks of training are not significantly 
different between sedentary, aerobic endurance training, and strength endurance 
30 
 
training groups among healthy humans (age 50s, females and males, not obese and 
diabetic) (Hecksteden et al., 2013). These differences may be due to the different 
samples sizes, health conditions (healthy vs. obese vs. diabetic), age (20s vs. 50s), and 
gender (male only vs. male/female mix) used in different studies.  
Recently, plasma irisin is detected by mass spectrometry in young healthy 
subjects. A high-intensity aerobic training group at over 70% aerobic capacity (3 
days/week cycle ergometer and 2 days/week walking on a treadmill for 12 weeks) has 
more plasma irisin than a sedentary group (Jedrychowski et al., 2015). Purified r-irisin 
(0.5 μg/g/d for 14 days using intraperitoneal injection) increases UCP-1 and PGC1α 
gene expression and UCP-1-positive adipocytes in subcutaneous WAT of C57BL/6 
mice fed a high-fat diet (60% fat) (Zhang et al., 2014). After 14 days, the body weight is 
decreased in irisin-injected mice compared to saline-injected mice fed a high-fat diet 
(Zhang et al., 2014). In addition, it has been shown that irisin increases UCP-1 and the 
thermogenic-related gene expression in the 3T3-L1 mature adipocytes (C. Wang et al., 
2015) and WAT of mice (Bostrom et al., 2012). Irisin could be a potential target to 
prevent obesity through the browning of WAT. More studies are still needed to 
determine the underlying mechanism of the browning effect of irisin. 
1.3.5 Nutritional intervention of BAT development and browning 
It has been shown that both BAT and the browning of WAT are responsible for 
energy expenditure in many ways, including thermogenesis, mitochondria biogenesis, 
and fatty acid oxidation (Bartelt & Heeren, 2014; Cereijo et al., 2015; Cohen & 
Spiegelman, 2015; P. Lee & Greenfield, 2015; Lidell, Betz, & Enerback, 2014; McMillan 
& White, 2015; Roman et al., 2015; Symonds, 2013; Virtanen et al., 2013; Vosselman et 
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al., 2013; Zafrir, 2013). Thus, several nutritional compounds have been experimentally 
established to increase BAT function and energy expenditure to prevent obesity (Bonet 
et al., 2013; S. Wang et al., 2014). 
Resveratrol is a type of natural polyphenolic compound found widely in the skins 
of grapes, red wine, and berries, and is well known as a protective agent against 
metabolic diseases (Lagouge et al., 2006). Numerous animal studies have supported 
the beneficial effects of resveratrol on obesity. Resveratrol reduces body weight and 
insulin resistance in high-fat diet-fed obese mice (C57BL6J) in the short term (400 
mg/kg/day in commercial high fat diet purchased from Research diet for 15 weeks), as 
well as in the long term (25 mg/kg/day in 54.35% fat diet for 20 months) (Lagouge et al., 
2006; Montero, de la Fuente, Fonteriz, Moreno, & Alvarez, 2014). Recently, resveratrol 
has been shown to promote cAMP-AMPK-PGC1α signaling, leading to the upregulating 
of mitochondria biogenesis and function (S. Wang et al., 2015). Lipid accumulation is 
significantly decreased in stromal vascular cells, isolated from inguinal WAT that are 
treated with 20 μM resveratrol.  
Differentiated stromal vascular cells treated with 10 μM resveratrol significantly 
increase BAT-specific genes, UCP-1, PGC1α, and PRDM16; beige adipocyte selective 
genes, CD137 and transmembrane protein (TMEM)26; and AMPK phosphorylation (S. 
Wang et al., 2015). An animal study has supported that feeding a high-fat diet (45% fat) 
containing 0.1% resveratrol to CD1 female mice results in reduced body weight, 
increased AMPK phosphorylation, and increased UCP-1 and PRDM16 expression, but 
not PPARγ expression, in contrast to control mice fed a high-fat diet only (S. Wang et 
al., 2015). The thermogenic gene and the BAT-specific marker, the UCP-1 gene, is also 
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upregulated in BAT of male mice fed a resveratrol containing diet (4g/kg) (Andrade et 
al., 2014). Resveratrol also has novel browning properties in cell models and affects the 
number of mitochondria and fatty acid oxidation and UCP-1 expression in 3T3-L1 
adipocytes (Mercader, Palou, & Bonet, 2011; Rayalam, Yang, Ambati, Della‐Fera, & 
Baile, 2008). Resveratrol (20 μM) increases palmitate oxidation in both primary mouse 
embryonic fibroblast-derived adipocytes and 3T3-L1 adipocytes. In addition, resveratrol 
significantly increases UCP-1 expression in primary mouse embryonic fibroblast-derived 
adipocytes, but not in 3T3-L1 adipocytes (Mercader et al., 2011). Another study, 
however, has shown that resveratrol (25 μM) significantly decreases lipid accumulation 
and increases UCP-1 expression in 3T3-L1 adipocytes (Rayalam et al., 2008).  
Polyunsaturated fatty acid (PUFA) contains two or more double bonds and 
includes the essential fatty acids, α-linolenic acid (ω-3) and linoleic acid (ω-6), which are 
known as anti-oxidant reagents (Buckley & Howe, 2010). Linoleic acid has provided 
browning effects in animal models. A diet containing linoleic acid (20% linoleic acid 
applied in 6.5% total lipid) increases UCP-1 and PGC1α gene expression in the 
epididymal WAT of leptin-deficient ob/ob mice (Wendel, Purushotham, Liu, & Belury, 
2009). In addition, the omega-3 PUFA, eicosapentaenoic acid (EPA, 20:5) and 
docosahexaenoic acid (DHA, 22:6) found in fish oil, diminish obesity in animals (Buckley 
& Howe, 2010). Wistar rats fed a standard diet supplemented with either EPA or DHA 
show significantly decreased body weight gain (-27.4 and -22.1%, respectively) 
compared to standard diet only (10.8%). In addition, high-fat diet supplemented with 
either EPA or DHA also reduces body weight gain (8.8 and 5.5%, respectively) 
compared to a high-fat diet alone (15.3%) in wistar rats (Poudyal, Panchal, Ward, & 
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Brown, 2013). Omega-3 PUFA-supplemented high-fat diet (44% of lipids are replaced 
by EPA and DHA) increases fatty acid oxidation and mitochondria biogenesis by 
increasing the PGC1α and NRF-1 gene expressions in the epididymal WAT of male 
C57BL/6J mice (Flachs et al., 2005). Moreover, EPA and DHA enhance BAT weight 
with higher mitochondrial protein in high-fat diet-fed male wistar rats (Oudart et al., 
1997).  
Capsaicin has also been studied in regard to its role in BAT function and 
browning effects (Yoneshiro, Aita, Kawai, Iwanaga, & Saito, 2012). Capsaicin can be 
found in peppers and spicy food ingredients (Hayman & Kam, 2008). Capsaicin has 
been confirmed as an anti-obesity reagent targeting WAT and weight control in 
numerous previous studies, from in vitro to clinical human studies (Hwang et al., 2005; 
Joo, Kim, Choi, & Yun, 2010; J.-H. Kang et al., 2011; J. H. Kang et al., 2010; M. S. Lee, 
Kim, Kim, & Kim, 2011; Lejeune, Kovacs, & Westerterp-Plantenga, 2003). Recently, 
several studies have shown that capsaicin promotes BAT thermogenesis and energy 
expenditure in animal and human studies (Okamatsu-Ogura et al., 2015; Saito & 
Yoneshiro, 2013; Yoneshiro et al., 2012). Capsaicin administration (0.3% w/w for 8 
weeks) together with exercise (free access to a running wheel) significantly increases 
BAT functions and lipolysis through cAMP-PKA pathways in high-fat diet-induced obese 
C57BL/6J mice (Ohyama et al., 2015). In addition, capsaicin (2 mg/kg BW dissolved in 
0.9% saline for 12 weeks) upregulates brown adipocyte-specific markers, including 
UCP-1, PGC1α, and cell death-inducing DNA fragmentation factor alpha-like effector A 
(CIDEA) in subcutaneous WAT of regular chow-fed LACA mice (Baboota et al., 2014). 
A low dose of capsaicin at 1μM inhibits lipid accumulation and induces browning 
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through enhanced beige adipocytes and brown adipocyte-specific markers in 3T3-L1 
adipocytes. In contrast, high dose of capsaicin at 100 μM increases lipid accumulation 
and decreases brown adipocytes-specific markers (Baboota et al., 2014). 
Ginsenoid Rb1 is a major component found in ginseng (Leung & Wong, 2010). A 
previous study has shown that ginsenoid Rb1 significantly enhances glucose tolerance 
and increases insulin sensitivity via AMPK activation in male rats (Shen et al., 2015). 
Very recently, it has been found that ginsenoid Rb1 (10 μM) promotes browning effects 
through the amplified expression of UCP-1, PGC1α, and PRDM16, increased 
mitochondria respiration measured by oxygen consumption rate (OCR), and PPARγ 
activation in 3T3-L1 adipocytes (Mu et al., 2015). 
In summary, various studies have shown evidence that BAT has properties 
related to energy expenditure while WAT is responsible for energy storage. Although 
BAT is detected in human adults, the amount of BAT is very low compared to infants. 
Instead, WAT increases with age, and human adults have plenty. Thus, the 
development of BAT as well as brown-like cells in WAT could have beneficial effects for 
the prevention of obesity. Understanding the mechanism of BAT function and the 
browning of WAT would be advantageous. The specific aims of this dissertation are to 
investigate whether 1) activation of PRRs induces inflammation and reduces UCP-1 and 
mitochondrial respiration in classic brown adipocytes; 2) activation of PRRs suppresses 
brown-like adipogenesis in C3H10T1/2 mesenchymal stem cells and brown 
preadipocytes; and 3) whether nutritional compound boosts brown adipocytes 
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ACTIVATION OF PATTERN RECOGNITION RECEPTORS IN BROWN 
ADIPOCYTES INDUCES INFLAMMATION AND SUPPRESSES 





A version of this chapter was originally published by Jiyoung Bae, Carolyn J. 
Ricciardi, Debora Esposito, Slavko Komarnytsky, Pan Hu, Benjamin J. Curry, Patricia L. 
Brown, Zhanguo Gao, John P. Biggerstaff, Jiangang Chen, Ling Zhao entitled 
“Activation of pattern recognition receptors in brown adipocytes induces inflammation 
and suppresses uncoupling protein 1 expression and mitochondrial respiration” 





Pattern recognition receptors (PRR), Toll-like receptors (TLR), and nucleotide-
oligomerization domain-containing proteins (NOD) play critical roles in mediating 
inflammation and modulating functions in white adipocytes in obesity. However, the role 
of PRR activation in brown adipocytes, which are recently found to be present in adult 
humans, has not been studied. Here, we report that mRNA of TLR4, TLR2, NOD1, and 
NOD2 is upregulated, paralleled with upregulated mRNA of inflammatory cytokines and 
chemokines in the brown adipose tissue (BAT) of the obese mice. During brown 
adipocyte differentiation, mRNA and protein expression of NOD1 and TLR4, but not 
TLR2 and NOD2, is also increased. Activation of TLR4, TLR2, or NOD1 in brown 
adipocytes induces activation of NF-κB and MAPK signaling pathways, leading to 
inflammatory cytokine/chemokine mRNA expression and/or protein secretion. Moreover, 
activation of TLR4, TLR2, or NOD1 attenuates both basal and isoproterenol-induced 
uncoupling protein 1 (UCP-1) expression without affecting mitochondrial biogenesis and 
lipid accumulation in brown adipocytes. Cellular bioenergetics measurements confirm 
that attenuation of UCP-1 expression by PRR activation is accompanied by suppression 
of both basal and isoproterenol-stimulated oxygen consumption rates and isoproterenol-
induced uncoupled respiration from proton leak; however, maximal respiration and ATP-
coupled respiration are not changed. Further, the attenuation of UCP-1 by PRR 
activation appears to be mediated through downregulation of the UCP-1 promoter 
activities. Taken together, our results demonstrate the role of selected PRR activation in 
inducing inflammation and downregulation of UCP-1 expression and mitochondrial 
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respiration in brown adipocytes. Our results uncover novel targets in BAT for obesity 





Brown adipose tissue (BAT) is a specialized tissue whose function is to produce 
heat through nonshivering thermogenesis. BAT is found in relative abundance in small 
eutherian mammals, such as rat or mice, to allow the animals to live in a cold 
environment without utilizing shivering mechanism to produce heat (Cannon & 
Nedergaard, 2004). The thermogenic property of BAT is conferred to mainly by the 
functions of uncoupling protein 1 (UCP-1), which is uniquely expressed and localized in 
the inner membrane of brown adipocyte mitochondria to uncouple ATP synthesis from 
respiration (Nicholls & Locke, 1984; Ricquier, 2005). BAT is heavily innervated by 
sympathetic efferent fibers, and the release of norepinephrine by these fibers not only 
increases BAT thermogenic activity (i.e., heat production) but also thermogenic capacity 
(i.e., brown adipogenesis, mitochondrial biogenesis, and synthesis of UCP-1 and other 
BAT thermogenic proteins) (Richard & Picard, 2011).  
It was thought until recently that humans only possess BAT when they were 
newborn infants and that BAT quickly regresses following birth. However, new evidence 
from positron emission tomography/computed tomography scanning has revealed 
symmetrical fat depots in the cervical, supreclavicular, and parasphinal regions in adult 
humans that have all the characteristics of BAT (Cypess et al., 2009; Saito et al., 2009; 
van Marken Lichtenbelt et al., 2009; Virtanen et al., 2009; Zingaretti et al., 2009). 
Recent gene expression profilings have confirmed many classical BAT features in the 
supraclavicular regions of adult humans (Cypess et al., 2013; Jespersen et al., 2013). 
Due to its energy-dissipating activity, BAT has become a novel target for obesity 
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treatment and prevention (Vijgen & van Marken Lichtenbelt, 2013; Vosselman, van 
Marken Lichtenbelt, & Schrauwen, 2013).  
In contrast to white adipose tissue (WAT), whose function is to store energy, 
brown adipocytes are multilocular with many small lipid droplets and contain a large 
number of mitochondria, compared with a single large lipid droplet and few mitochondria 
in white adipocytes. It is now recognized that obesity is associated with chronic 
inflammation in WAT at both local and systemic levels. Adipose inflammation, 
characterized by elevated pro inflammatory cytokine/chemokine expression and 
secretions and infiltration of immune cells, including macrophages, is thought to 
contribute to obesity associated comorbidities, such as insulin resistance and diabetes 
(Gregor & Hotamisligil, 2011; Kwon & Pessin, 2013; Ouchi, Parker, Lugus, & Walsh, 
2011; Rasouli & Kern, 2008).  
The mechanisms underlying adipose inflammation in obesity have been the 
focus of intense research (Sun, Ji, Kersten, & Qi, 2012). Recent studies suggest that 
adipose inflammation is mediated through the activation of germline-encoded pattern 
recognition receptors (PRR) in the adipose tissue/adipocytes (Jin, Henao-Mejia, & 
Flavell, 2013). PRRs belong to innate immune system and are responsible for the 
sensing of invading microbial pathogens and activate specific signaling pathways 
leading to distinct inflammatory and immune responses in the host cells (Akira, 
Uematsu, & Takeuchi, 2006; Kawai & Akira, 2009). Toll-like receptors (TLR) and Nod-
like receptors (NLR) are two prominent families of PRRs. TLRs are transmembrane 
receptors composed of extracellular leucine-rich repeat (LRR) motifs and a cytoplasmic 
Toll/interleukin-1 receptor (TIR) homology domain. So far, 10 and 12 functional TLRs 
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have been identified in humans and mice, respectively. The respective bacterial or viral 
pathogen-associated molecular patterns (PAMP) that individual TLR detects have been 
characterized (Akira et al., 2006). In contrast, NLRs are a family of cytosolic sensors 
that play important roles in innate immunity and inflammation (Inohara, Chamaillard, 
McDonald, & Nunez, 2005). These NLRs display a central nucleotide-binding domain, 
an NH2-terminal protein interaction domain, and a COOH-terminal LRR domain. Two 
prominent members of NLRs are NOD1 and NOD2, and each recognizes a distinct 
minimal peptidoglycan structure: NOD1 recognizes a dipeptide, γ-D-Glu-meso-
diaminopimelic acid (iE-DAP) (Chamaillard et al., 2003), or a tripeptide, L-Ala-γ-D-Glu-
meso-diaminopimelic acid (Tri-DAP) (Girardin, Boneca, Carneiro, et al., 2003) derived 
mostly from Gram-negative bacteria; NOD2 recognizes the peptidoglycan muramyl 
dipeptide MurNAc-L-Ala-D-isoGln (MDP) from both Gram-positive and Gram-negative 
bacteria (Girardin, Boneca, Viala, et al., 2003; Inohara et al., 2003). Various PRRs, 
including TLR4, TLR2, NOD1, and NOD2, have been detected in WAT and/or white 
adipocytes, and activation of PRR induces a proinflammatory response (Davis, 
Braucher, Walker-Daniels, & Spurlock, 2011; Song, Kim, Yoon, & Kim, 2006; Zhao, Hu, 
Zhou, Purohit, & Hwang, 2011), resulting in adipocyte dysfunction and disturbed 
homeostasis of whole body metabolism (Ehses et al., 2010; Himes & Smith, 2010; 
Schertzer et al., 2011; Shi et al., 2006).  
Here, we report the expression of NOD1, NOD2, TLR4, and TLR2 in classical 
BAT of mouse models of obesity and during brown adipocyte differentiation. Activation 
of NOD1, TLR4, and TLR2, but not NOD2, induces a proinflammatory response in 
brown adipocytes through NF-κB and MAPK signaling pathways. Moreover, the 
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activation of these selected PRRs leads to downregulation of basal and isoproterenol-
induced UCP-1 mRNA and protein expression and suppresses mitochondrial respiration 




2.3 Materials and methods 
Reagents 
NOD1 synthetic ligand lauroyl-γ-D-Glu-meso-diaminopimelic acid (C12-iEDAP) 
and TLR2 ligand a synthetic triacylated lipoprotein Pam3CSK4 were from Invivogen 
(San Diego, CA). Ultra pure TLR4 ligand lipopolysaccharide (LPS) was from List 
Biological Laboratories (Campbell, CA). 3-Isobutyl-L-methylxanthine, T3, 
dexamethasone, insulin, indometacin, and isoproterenol were from Sigma (St. Louis, 
MO). The pharmacological MAPK inhibitors PD98054, SP600125, and SB203580 were 
from Tocris Bioscience (Ellisville, MI), and the NF-κB inhibitors QNZ and caffeic acid 
phenethyl ester (CAPE) were from Cayman Chemical (Ann Arbor, MI). Antibodies anti-
phospho-ERK1/2(Thr202/Tyr204) (no. 4376), anti-ERK1/2 (no. 4695), anti-phospho-
p38(Thr180/Tyr182) (no. 9211), anti-p38 (no. 9212), anti-phospho-JNK(Thr183/Tyr185) 
(no. 9251), anti-JNK (no. 9258), anti-phospho-p65(Ser536) (no. 3033), anti-p65 (no. 
3034), anti-phospho-IκB(Ser32) (no. 2859), anti-proliferator-activated receptor-gamma 
(PPARγ; no. 2443) were from Cell Signaling Technology (Danvers, MA). Anti-UCP-1 
antibody (U6382) was from Sigma-Aldrich (St. Louis, MO). Anti-peroxisome proliferator-
activated receptor-gamma coactivator-1α (PGC-1α) antibody (AB3242) was from 
Millipore (Temecula, CA). Antibodies anti-NOD1 (ab105338), anti-TLR4 (ab13867), and 
anti-TLR2 (ab108998) were from Abcam (Cambridge, MA). 
Animals 
Diet-induced obesity (DIO) mice and ob/ob and their respective controls have 
been described previously (Zhao et al., 2011). The mice were purchased from the 
Jackson Laboratory (Bar Harbor, ME). For DIO study, male C57BL/6J mice (n=7 per 
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group) were fed with a high-fat diet (60% Kcal% from fat; Research Diets) or regular 
chow diet for 20 wk before being killed at 26 wk of age. Male ob/ob and their control 
mice (n=6 per group) were fed with chow diet for 8 wk before being killed at 14 wk of 
age. Upon death, interscapular BAT was removed and immediately snap frozen in liquid 
nitrogen and stored at -80°C until analysis. The mice studies were approved by the 
Institutional Animal Care and Use Committee at the University of Tennessee. 
Brown fat cell culture and differentiation 
The murine brown fat cell line was a generous gift from Dr. Johannes Klein 
(University of Lubeck, Lubeck, Germany), who has generated the cell line from the 
interscapular brown fat of 6- to 7-wk-old of C57BL mice (Klein, Fasshauer, Klein, Benito, 
& Kahn, 2002). Brown fat cells were maintained in DMEM supplemented with 20% fetal 
bovine serum (FBS; Atlas Biologicals, Fort Collins, CO) at 37°C humidified atmosphere 
of 5% CO2 in air until they reached confluence [designated as day 0 (D0)]. The cells 
were changed into differentiation media DMEM supplemented with 20% FBS, 1 nM T3, 
and 20 nM insulin for 24 h, followed by induction in DMEM supplemented with 20% 
FBS, 1 nM T3, 20 nM insulin, 0.125 mM indometacin, 5 μM dexamethasone, and 0.5 
mM 3-isobutyl-L-methylxanthine for another 24 h. The cells were then changed back to 
differentiation media and subsequently changed every 2 days until fully differentiated 
into brown adipocytes on day 6 (D6). 
PRR stimulation 
Differentiated brown adipocytes were serum starved in DMEM containing 1% 
FBS for 12–15 h and stimulated with vehicle control, C12-iEDAP, LPS, or Pam3CSK4 
as indicated. Total RNA and media were collected for cytokine/chemokine mRNA 
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expression and protein secretion analysis. For the studies using the inhibitors of NF-κB 
or MAPK, cells were pretreated with the inhibitor for 1 h and were co-stimulated with the 
respective ligand for the indicated time. 
Western blot analysis 
Total cell lysates were prepared and protein concentrations were determined by 
the BCA assay kit (Thermo Scientific, Waltham, MA). Fifty micrograms of total cell 
lysates were subjected to 10% SDS-PAGE and transferred to polyvinylidene difluoride 
membrane (Bio-Rad, Hercules, CA). The membrane was blocked in 20 mM Tris·HCl, 
137 mM NaCl, and 0.1% Tween 20 (pH 7.4) containing 5% nonfat milk. The membrane 
was immunoblotted with primary antibodies at 4°C overnight followed by secondary 
antibody conjugated with horseradish peroxidase (GE Healthcare). The signal was 
quantified by densitometry using a ChemiDocXRS+ imaging system with ImageLab 
software (Bio-Rad). 
RNA preparation and quantitative real-time PCR analysis 
Total RNA was prepared from BAT from DIO or ob/ob mice or from brown 
adipocytes using TRI reagent (Molecular Research Center, Cincinnati, OH) according to 
the manufacturer’s instructions. Total RNA abundance was quantified using NanoDrop 
ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Reverse 
transcription was carried out using Fermentas first strand synthesis kit (Thermo 
Scientific, Pittsburgh, PA) according to the manufacturer’s instructions. mRNA 
expression of PRRs, brown adipocyte marker genes, inflammatory cytokine/chemokine 
genes, and the housekeeping gene 36B4 was measured quantitatively using gene-
specific TaqMan gene expression assays (Applied Biosystems) (for samples of BAT) or 
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Absolute Blue QPCR SYBR Green ROX mix (Thermo Fisher Scientific) and gene-
specific primers (for samples of brown adipocytes). Specific primer sequences can be 
provided upon request. PCR reactions were run in a 96-well format using an ABI 
7300HT instrument. Cycle conditions were 50°C 2 min, 95°C 15 min and then 40 cycles 
of 95°C for 15 s/60°C for 1 min. Relative gene expression was calculated using the 2-
ΔΔCt method, which normalizes against 36B4. 
Reporter gene assays 
For NF-κB-Luc experiments, brown adipocytes in 24-well plates were infected 
with adenovirus encoding NF-κB-Luc reporter gene for 24 h. The cells were stimulated 
with C12-iEDAP, LPS, Pam3CSK4, or the vehicle control for 15 h. For UCP-1-Luc 
experiments, brown adipocytes were subcultured and transfected with a mouse 3.1 kb 
UCP-1 promoter luciferase construct (UCP-1-Luc) (Rim & Kozak, 2002) and 
subsequently pretreated with the ligand for each PRR or the vehicle control for 1 h and 
then cotreated with isoproterenol for 15 h. The cell lysate was prepared and reporter 
luciferase activities were measured with GloMax Luminometer (Promega, Madison, WI). 
Relative luciferase activities were normalized by protein concentrations and expressed 
as fold of vehicle control.  
Measurement of cytokine/chemokine 
The supernatant from brown adipocytes that were stimulated with PRRs was 
collected and the levels of monocyte chemotactic protein 1 (MCP-1), interleukin 6 (IL-6), 
and regulated upon activation, normal T-cell expressed, and secreted (RANTES) were 
determined by ELISA using Quantikine kits (R&D Systems, Minneapolis, MN). 
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Oil red O staining and quantification 
Differentiated brown adipocytes were serum-starved overnight and were treated 
with C12-iEDAP, LPS, and Pam3CSK4 for 12 h under the basal condition, or pretreated 
with C12-iEDAP, LPS, Pam3CSK4, or the vehicle control for 12 h, followed by co-
stimulated with isoproterenol (1 μM) in the presence of the ligand for another 6 h. The 
cells were fixed, and lipid accumulation in brown adipocytes was stained with oil red O 
(ORO) and quantified by ORO absorbance at 500 nm. 
Cellular bioenergetics measurements 
D6 2.5x104 brown adipocytes were subcultured and seeded in 24-well XF assay 
plates overnight in the differentiation medium and subjected to real-time measurements 
of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) using 
XF24 Extracellular Flux Analyzer (Seahorse Biosciences, North Billerica, MA). To study 
the effects of PRR ligands on bioenergetics of brown adipocytes, cells were pretreated 
with C12-iEDAP (10 μg/ml), LPS (0.1 μg/ml), Pam3CSK4 (1 μg/ml), or the vehicle 
control for 12 h, rinsed once, changed to 500 μl of XF assay buffer (DMEM without 
NaHCO3, 10 mM glucose, 2 mM pyruvate, and 2 mM GlutaMAX, pH 7.4), and 
equilibrated at non-CO2 incubator and 37°C for 1 h. Following basal measurements of 
OCR and ECAR, all cells were injected either with the vehicle control or isoproterenol (1 
μM) and the subsequent readings were taken over the 6 h period. At the end of the 
experiment, mitochondrial complex inhibitors were injected to all treatments sequentially 
in the following order: oligomycin (1 μM), carbonyl cyanide-
ptrifluoromethoxyphenylhydrazone (FCCP; 0.75 μM), and antimycin A/rotenone (1 μM 
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each), and three readings were taken after each inhibitor. OCR and ECAR were 
automatically recorded by XF24 software v1.8 provided by the manufacturer.  
Basal and isoproterenol-stimulated OCR and ECAR rates were determined by 
averaging the measurements. Calculations of maximal OCR, ATP-coupled OCR, OCR 
from proton leak, spare respiration capacity, and coupling efficiency were performed 
according to the manufacturer’s instructions. 
Analysis of mitochondrial content by MitoTracker green staining 
Mitochondria were labeled using the mitochondria-specific dye MitoTracker 
Green (Life Technologies, Carlsbad, CA) according to manufacturer’s protocol. Briefly, 
the differentiated brown adipocytes were washed and trypsinized from the cultured plate 
and incubated with MitoTraker green at 100 nM for 30 min at 37°C. The fluorescence 
intensity was measured with Accuri C6 flow cytometry (BD, Franklin Lakes, NJ). 
Background autofluorescence from nonstained cells was averaged and subtracted from 
the mean fluorescence intensity values. 
Statistical analysis 
All data are presented as means±SE. Measurements were performed in 
triplicates. Statistical analysis was performed using SigmaPlot 11.0 (Systat Software). 
One-way ANOVA with repeated measures followed by multiple comparisons test 
(Student-Newman-Keuls method) was performed to determine the differences between 
the treatment groups and/or time points. Student’s t-tests were performed when 





mRNA expression of selected PRRs is upregulated in brown fat tissue of DIO and 
ob/ob mice  
We first examined selected PRRs NOD1, NOD2, TLR4, and TLR2 mRNA 
expression in the classical interscapular BAT from DIO and ob/ob mice, compared with 
their respective controls (Figure 1A and 1B). In DIO mice, NOD1 and TLR4 were two 
highly expressed PRRs, followed by NOD2 and TLR2, similar to those of their chow-fed 
controls. Moreover, NOD1, TLR4, and TLR2 mRNA was significantly upregulated 
(p<0.05) in DIO mice compared with their controls (Figure 1A). Similar relative 
expression patterns were observed in BAT of ob/ob mice compared with their wild-type 
(WT) controls (Figure 1B). Further, we examined inflammatory gene expression in BAT 
from DIO and ob/ob mice. mRNA of MCP-1, IL-6 and TNF-α, but not RANTES, was 
significantly upregulated in BAT of DIO mice compared with the chow-fed controls 
(p<0.01 for MCP-1 and TNF- and p<0.05 for IL-6; Figure 1C). mRNA of all four genes 
were significantly upregulated in BAT of ob/ob mice compared with the WT controls 
(p<0.01 for MCP-1 and p<0.05 for IL-6, TNF-α, and RANTES; Figure 1D). These results 
demonstrate that upregulation of selected PRRs is correlated with the upregulation of 
mRNA of proinflammatory genes in BAT in mice models of obesity. 
Expression of selected PRRs is upregulated during brown adipocyte 
differentiation 
To study the relationships between the upregulation of PRRs and inflammatory 
genes in BAT, we employed an immortalized brown fat cell line generated from the 
classical interscapular brown fat from C57BL6 mice (Klein et al., 2002). In vitro brown 
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adipocyte differentiation was validated by the increasing mRNA expression of known 
brown adipocyte markers UCP-1, PGC-1α, and PPARγ (Figure 2A, bottom). mRNA 
expression of NOD1 and TLR4, but not NOD2 and TLR2, was upregulated during 
differentiation (Figure.2A, top). Comparing the relative PRR expression pattern, NOD1 
was the highest expressed PRR examined in brown fat cells before differentiation, 
followed by TLR4 and TLR2, and NOD2 had the lowest expression. In contrast, both 
NOD1 and TLR4 were among the highest expressed PRRs, followed by TLR2 and 
NOD2 after differentiation (Figure 2B). Western analysis and relative quantification 
confirmed that NOD1 and TLR4 were increased, whereas TLR2 was decreased upon 
differentiation (Figure 2C). NOD2 protein expression was undetectable by Western 
analysis (data not shown). These results suggest NOD1, TLR4, and TLR2 may be 
involved in mediating inflammation and modulating functions in brown adipocytes. 
PRR activation in brown adipocytes induces phosphorylation and activation of 
NF-κB and MAPK signaling 
Activation of PRR leads to NF-κB and MAPK signaling pathways in various PRR 
expressing cells, including white adipocytes. Because of the relative higher expression 
levels of NOD1, TLR4, and TLR2 than NOD2 in brown adipocytes, we focused on the 
signaling pathways downstream of NOD1, TLR4, and TLR2 activation in brown 
adipocytes by stimulating the cells with their respective synthetic ligands. NF-κB 
pathway was activated as shown by the phosphorylation of p65 and IκBα when 
stimulated with NOD1 ligand C12-iEDAP, TLR4 ligand LPS, or TLR2 ligand Pam3CSK4 
in a time-dependent manner (Figure 3A). Moreover, MAPK pathways were also 
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activated within 60 min after the stimulation, as shown by the phosphorylation of p38, 
JNK, and ERK when stimulated with C12-iEDAP, LPS, or Pam3CSK4 (Figure 3A). 
We further confirmed that activation of NOD1, TLR4, and TLR2 induced NF-κB 
activation with NF-κB-responsive luciferase reporter assays in brown adipocytes by 
transiently infecting the brown adipocytes with the adenovirus encoding NF-κB-Luc 
receptor gene. Activation of NOD1, TLR4, and TLR2 dose-dependently induced NF-κB 
reporter activation (Figure 3B). In contrast, NOD2 ligand MDP induced minimal NF-κB 
activation even when used up to 100 μg/ml in brown adipocytes (data not shown). 
PRR activation in brown adipocytes upregulates the mRNA expression and 
protein secretion of proinflammatory cytokines/chemokines 
Consequently, we found that activation of NOD1, TLR4, and TLR2 significantly 
increased mRNA expression of chemokine MCP-1, cytokine IL-6, RANTES, and tumor 
necrosis factor alpha (TNF-α; p<0.01 or p<0.05; Figure 4A). Other than TNF- α, which 
was below detection limit, protein secretion in the supernatant of the brown adipocytes 
was confirmed for MCP-1, IL-6, and RANTES by ELISA (Figure 4B). 
Inhibitory of the NF-κB or MAPK pathways differentially attenuates 
proinflammatory mRNA expression in brown adipocytes 
To determine if NF-κB or MAPK signaling pathway underlies proinflammatory 
cytokine or chemokine mRNA expression, we examined the effects of the 
pharmacological inhibitors of these pathways on mRNA expression on the 
cytokines/chemokines. NF-κB inhibitor QNZ (Tobe et al., 2003) and CAPE (Natarajan, 
Singh, Burke, Grunberger, & Aggarwal, 1996) significantly attenuated C12-iEDAP, LPS 
or Pam3CSK4-induced MCP-1, IL-6, RANTES, and TNF-α in brown adipocytes (Figure 
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5), suggesting NF-κB pathway is involved in NOD1-, TLR4-, or TLR2-mediated 
inflammatory cytokine/chemokine expression. 
Among the inhibitors of MAPKs, only the p38 inhibitor SB203580 significantly 
attenuated C12-iEDAP-induced MCP-1, IL-6, TNF-α, and RANTES mRNA expression 
(Figure 6). In contrast, the JNK inhibitor SP600125 significantly attenuated LPS-induced 
all four mRNA. The ERK inhibitor PD98054 significantly attenuated LPS-induced IL-6, 
TNF-α, and RANTES mRNA, but not MCP-1 mRNA, whereas the p38 inhibitor 
SB203580 did not affect any of the four mRNA induced by LPS. The p38 inhibitor 
SB203580 significantly attenuated Pam3CSK4-induced IL-6 and RANTES mRNA, and 
the ERK inhibitor PD98054 only attenuated Pam3CSK4-induced MCP-1 and IL-6 
mRNA, whereas the JNK inhibitor SP600125 attenuated Pam3CSK4-induced MCP-1, 
TNF-α, RANTES, but not IL-6 (Figure 6). 
PRR activation suppresses both basal and isoproterenol-inducted UCP-1 
expression, but not mitochondrial biogenesis, in brown adipocytes 
The main function of brown adipocytes is mediated by UCP-1 to uncouple 
oxidative phosphorylation from ATP synthesis to produce heat and UCP-1 is known to 
be predominantly regulated at transcriptional level (Richard & Picard, 2011). We next 
examined whether PRR activation in brown adipocytes affects UCP-1 mRNA 
expression. Activation of NOD1, TLR4, and TLR2 suppressed both basal and 
isoproterenol, a nonspecific β-adrenergic agonist, -induced UCP-1 mRNA expression 
(Figure 7A). We also examined other brown adipocyte markers. Similar suppression 
was observed for cell-death inducing DFFA-like effector a (Cidea), and distinct but 
different changes were observed for PGC-1α and PPARγ. PPARγ mRNA was 
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suppressed by activation of NOD1, TLR4, or TLR2 under basal and isoproterenol -
induced conditions. In contrast, PGC-1α mRNA was only suppressed by the activation 
of the PRR under the basal condition. Moreover, no changes were observed for nuclear 
respiratory factor 1 (Nrf1) and transcription factor A (Tfam), and two nucleus encoded 
mitochondrial genes, cytochrome c oxidase subunit IV a (COX4a) and cytochrome b-
c1complex subunit 6 (Uqcrh) (Figure 7A). Western analysis and relative quantification 
confirmed that UCP-1 expression was suppressed by the activation of NOD1, TLR4, 
and TLR2 in brown adipocytes under both conditions but more pronounced under 
isoproterenol-stimulated condition (Figure 7B). PPARγ protein expression was markedly 
suppressed by the PRR activation under both conditions, similar to that of PPARγ 
mRNA. In contrast, the PGC-1α protein was not affected by PRR activation under both 
conditions in brown adipocytes. We further examined the effects of PRR activation on 
brown adipocyte cell morphology and lipid accumulation. Under our experimental 
conditions, there were no significant changes in cell morphology (data not shown) and 
lipid accumulation, revealed by ORO staining, by the activation of NOD1, TLR4, or 
TLR2 under both conditions (Figure 7C).  
To test whether suppression of UCP-1 mRNA by PRR activation is a direct effect 
on the UCP-1 promoter or due to the effects on mitochondrial biogenesis, we performed 
UCP-1 promoter-driven reporter assays and confirmed that the effects of PRR activation 
was via suppressing UCP-1 promoter activities (Figure 7D). Consistent with the above 
mRNA expression results, PRR activation did not affect mitochondrial biogenesis as 
revealed by the staining of mitochondrial specific fluorescence mitoTracker Green 
(Figure 7E). Taken together, these results suggest that PRR activation in brown 
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adipocytes suppresses both basal and isoproterenol-induced UCP-1 expression at least 
in part through downregulation of the UCP-1 promoter, but not through modulation of 
mitochondrial biogenesis.  
PRR activation suppresses mitochondrial respiration in brown adipocytes 
To further determine whether the suppression of UCP-1 by PRR activation leads 
to changes in mitochondrial respiration, we performed cellular bioenergetics 
measurements in brown adipocytes using XF24 Extracellular Flux Analyzers (Figure 8). 
It has been determined that the activation of NOD1, TLR4, TLR2 did not change cell 
viability as measured by the MTT assays (data not shown). The basal oxygen 
consumption rate (OCR) of brown adipocytes was 109±10.02 pM/min, which was 
suppressed to 93±8.4, 79.9±5.5, and 82.5±9.79 pM/min by C12-iEDAP (p<0.05), LPS 
(p<0.01), and Pam3CSK4 (p<0.01), respectively (Figure 8C). Injection of isoproterenol 
(1 μM) resulted in a gradual increase in OCR that peaked at 142.2±21.1 pM/min 
(p<0.05), which was significantly reduced to 99.3±10, 92±8.7, and 76.8±3.4 pM/min by 
C12-iEDAP (p<0.05), LPS (p<0.01), and Pam3CSK4 (p<0.01), respectively (Figure 8C). 
The ECAR, an indirect measure of glycolysis and lactate production, was measured 
simultaneously with OCR. Brown adipocytes treated with C12-iEDAP (p<0.05), LPS 
(p<0.01), and Pam3CSK4 (p<0.05) all showed a significant increase in basal ECAR, 
with LPS inducing the highest level. Injection of isoproterenol induced a modest but 
significant increase in ECAR over the baseline (p<0.05); however, both C12-iEDAP and 
Pam3CSK4 significantly suppressed isoproterenol-induced ECARs (p<0.05). LPS 




Further calculations revealed that PRR activation did not affect isoproterenol-
induced maximal respiration (Figure 8E) and ATP-generating OCR (Figure 8F), but 
significantly suppressed isoproterenol-induced uncoupled OCR from proton leak (Figure 
8G) and increased coupling efficiency (Figure 8H). Taken together, these results show 
that PRR activation significantly attenuates basal and isoproterenol-induced OCR and 
isoproterenol-induced uncoupled respiration from proton leak, but does not affect 
maximal respiration and ATP-coupled respiration, consistent with the suppressive 





It has been well recognized that obesity is associated with chronic inflammation, 
both systemically and locally in WAT. Here we report, for the first time, that mRNA of 
major PRR NOD1, TLR4, and TLR2, but not NOD2, was upregulated in BAT, which was 
paralleled by the mRNA expression of the inflammatory chemokine MCP-1 and 
cytokines IL-6 and TNF-α in both DIO and ob/ob mice compared with their respective 
controls (Figure 1). Using an immortalized brown cell line derived from the classical 
interscapular BAT, we show that both mRNA expression and protein expression of 
NOD1 and TLR4, but not NOD2 or TLR2, were increased upon brown adipocyte 
differentiation (Figure 2); the activation of NOD1, TLR4, and TLR2 induced activation of 
the NF-κB and MAPK signaling pathways (Figure 3), leading to upregulation of mRNA 
and/or protein expression of the proinflammatory gene MCP-1, IL-6, RANTES, and 
TNF-α, in the cultured brown adipocytes (Figure 4-6). Moreover, activation of these 
PRRs in the brown adipocytes suppressed basal and isoproterenol-induced UCP-1 
mRNA and protein expression (Figure 7A and B), at least in part through suppressing 
UCP-1 promoter activities (Figure 7D). Further, PRR activation suppressed both basal 
and isoproterenol-induced oxygen consumption rates (Figure 8C), and isoproterenol-
induced uncoupled respiration from proton leaks (Figure 8G) and increased coupling 
efficiency (Figure 8H), but did not affect the maximal respiration (Figure 8E) and ATP-
generating respiration (Figure 8F).  
BAT has emerged as a novel target for obesity treatment and prevention, due to 
its unique role in energy expenditure. Two sources of brown adipocytes have been 
identified. One is from classical BAT depots, such as interscapular region, the other one 
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is from UCP-1 expressing, brown-like adipocytes from WAT depots, such as 
subcutaneous depot. While it is still unclear about the formation of the brown-like 
adipocytes in typical WAT, it is less debated that classical brown adipocytes share a 
common progenitor with skeletal muscle, different from that of brown-like adipocytes 
from WAT. The findings that adult humans do have classical BAT argue for research on 
classical BAT depots in rodents as they also have relevance to human physiology 
(Nedergaard & Cannon, 2013). To our knowledge, this is the first report demonstrating 
that the upregulation of mRNA expression of the selected PRRs in the classical BAT in 
obesity and the regulation of PRR expression at both mRNA and protein levels in 
differentiating brown adipocytes in culture. Our report further shows that activation of 
selected PRRs induces the proinflammatory response and suppresses UCP-1 
expression, which are accompanied by attenuated mitochondrial respiration in cultured 
brown adipocytes. Our results suggest that PRR-mediated inflammation in BAT may be 
targets for modulation of brown adipose function to combat against obesity.  
It is well recognized that PRRs are capable of sensing the disturbance from not 
only the immune system but also metabolism, the homeostasis of both processes is 
important for the survival of the organisms (Hotamisligil & Erbay, 2008; Jin et al., 2013). 
It is believed that the disturbances in obesity, i.e., the ligands for the PRRs, are excess 
of nutrients e.g., saturated fatty acids (Könner & Brüning, 2011), production of 
endogenous molecules from metabolic stress and tissue injuries e.g., ceramides 
(Fischer et al., 2007), and high mobility group box 1 (Li et al., 2011), or modulation of 
intestinal microbiota (Cani et al., 2007; Nicholson et al., 2012). Whether these ligands 
activate PRR in BAT in obesity remains to be determined in the future. 
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Mouse models of global deficiency of the PRRs have been instrumental in 
determining the role of PRRs in linking inflammation and metabolic stress. The effects 
of global deficiency of TLR4 and TLR2 on DIO, tissue inflammation, and insulin 
resistance have been reported (Davis et al., 2011; Ehses et al., 2010; Himes & Smith, 
2010; Shi et al., 2006; Tsukumo et al., 2007). Shi et al. (Shi et al., 2006) reported that 
only female mice lacking TLR4 were partially protected from high-fat DIO and insulin 
resistance, accompanied by less inflammation in the liver and fat (with no specification 
of fat type) compared with the WT control mice; however, energy expenditure was not 
reported. Male C3H/HeJ mice, which have a loss-of-function mutation in TLR4, were 
reported to be protected against the development of DIO with increased oxygen 
consumption (indicating the increased metabolic rate), and decreased respiratory 
exchange ratio (indicating the preferential use of fat as an energy source), improved 
insulin sensitivity, and enhanced insulin-signaling in white adipose tissue, muscle, and 
liver, compared with the controls. Inflammation of brown adipose was not reported in 
this study (Tsukumo et al., 2007). Moreover, global TLR2 deficiency protected the mice 
from DIO (Ehses et al., 2010; Himes & Smith, 2010; Kuo et al., 2011), liver, muscle 
(Ehses et al., 2010; Kuo et al., 2011), and pancreatic β-cells (Ehses et al., 2010). TLR2-
deficient mice showed an increase in energy expenditure as measured by oxygen 
consumption (VO2) in the dark cycle (Ehses et al., 2010; Kuo et al., 2011). In these 
studies, inflammation in BAT was not reported. Furthermore, mice with double knockout 
of NOD1 and NOD2 were shown to be protected from high-fat DIO, insulin resistance, 
inflammation in the white adipose and the liver (Schertzer et al., 2011). Energy 
expenditure and inflammation in brown adipose were not reported in this study 
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(Schertzer et al., 2011). Therefore, the role of PRR-mediated inflammation in BAT in 
diet-induced systemic inflammation, insulin resistance, and altered energy expenditure 
in obesity remains to be determined. 
Our results show that mRNA of selected PRR (NOD1, TLR4, TLR2, and NOD2) 
was upregulated in BAT in obesity, which correlated with increased mRNA expression 
of proinflammatory cytokines/chemokines, i.e., MCP-1, IL-6, TNF-α, and RANTES 
(Figure 1). MCP-1 has been reported to be a critical chemotactic factor for macrophage 
infiltration into the adipose tissue, leading to adipose inflammation (Kamei et al., 2006; 
Kanda et al., 2006). TNF-α and IL-6 are known cytokines that induce insulin resistance 
in skeletal muscle and liver (Rasouli & Kern, 2008). RANTES has also been reported to 
be upregulated and is associated with T-cell accumulation in murine and human obesity 
(Wu et al., 2007). Activation of NOD1, TLR4, and TLR2 is capable of inducing MCP-1, 
IL-6, RANTES, and TNF-α mRNA as well as protein secretion (except for TNF-α, which 
is below detection limit) in brown adipocytes (Figure 4). The differences in patterns 
between protein secretion and mRNA expression downstream of PRRs may reflect the 
differences in posttranscriptional modulation of those cytokines/chemokines 
downstream of the PRR activation in brown adipocytes. Using pharmacological 
inhibitors of NF-κB and MAPK, we show these pathways were differentially involved in 
mRNA expression of MCP-1, IL-6, TNF-α, and RANTES downstream of NOD1, TLR4, 
and TLR2 (Figure 5 and 6). While the NF-κB pathway appeared to be involved in all four 
examined cytokines/chemokines induced by C12-iEDAP, LPS, or Pam3CSK4, the 
involvement of MAPK seemed to differ among the activation of NOD1, TLR4, and TLR2. 
NOD1 activation primarily induced p38 MAPK as inhibition of p38 MAPK, but not other 
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MAPKs, attenuated mRNA of all four cytokines/chemokines. In contrast, differential yet 
distinct involvements of MAPKs downstream of activation of TLR4 and TLR2 were 
noted in brown adipocytes. The JNK inhibitor SP600125 significantly attenuated, 
whereas the p38 inhibitor SB203580 did not affect the mRNA of the four 
proinflammatory genes induced by LPS. The ERK inhibitor PD98054 significantly 
attenuated LPS-induced IL-6, TNF-α, and RANTES mRNA, but not MCP-1 mRNA. On 
the other hand, the JNK inhibitor SP600125 attenuated Pam3CSK4-induced mRNA of 
MCP-1, TNF-α, RANTES, but not IL-6, whereas the p38 inhibitor SB203580 only 
significantly attenuated Pam3CSK4-induced IL-6 and RANTES mRNA and the ERK 
inhibitor PD98054 only attenuated Pam3CSK4-induced MCP-1 and IL-6 mRNA. That 
distinct intracellular signaling pathways downstream of various PRRs control 
cytokines/chemokine expression, which has been reported in other cell types (Kopp et 
al., 2009; Natarajan et al., 1996), make it possible to design specific strategies to target 
individual PRR or cytokine/chemokine for the benefits of enhancing the functions of 
brown adipocytes. 
Moreover, our results demonstrate that PRR activation led to down-regulation of 
both basal and isoproterenol-stimulated UCP-1 mRNA as well as protein expression 
with more pronounced suppression under isoproterenol-stimulated condition (Figure 7A 
and B). These were accompanied by attenuated basal and isoproterenol-stimulated 
oxygen consumption and uncoupled respiration from proton leaks, but not maximal 
respiration and ATP-generated respiration (Figure 8). Initial mechanistic studies show 
that PRR-mediated downregulation of UCP-1 mRNA was not due to suppression of 
mitochondrial biogenesis as there were no changes in mRNA of two other mitochondrial 
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genes (COX4a and Uqcrh) (Figure 7A) and no changes of mitochondrial biogenesis by 
mitoTracker staining (Figure 7E). In contrast, similar degrees of suppression of UCP-1 
promoter activities were observed (Figure 8D). Taken together, these results 
demonstrate that PRR activation suppresses UCP-1 expression, leading to attenuated 
mitochondrial respiration, via at least in part down regulation of UCP-1 promoter 
activities. One of the possible mechanisms for PRR-mediated suppression of UCP-1 
promoter is through NF-κB pathway, since we have shown that PRR activation leads to 
NF-κB activation in brown adipocytes, and a few putative NF-κB transcriptional factor 
binding sites have been identified upstream of the transcription start site using 
bioinformatics tools. The molecular mechanisms underlying the cross talk between NF-
κB pathway downstream of PRR activation and UCP-1 transcription under the basal or 
β-adrenergic stimulation need to be explored further. 
Compared with UCP-1 expression, PRR activation at the same time also 
differentially affected PPARγ and PGC-1α expression, both of which are important for 
the expression of brown adipocyte markers, such as UCP-1. Evidence has emerged 
from studies that PPARγ not only controls white adipocyte differentiation but also 
controls brown adipocyte differentiation (Gray et al., 2006; Petrovic, Shabalina, 
Timmons, Cannon, & Nedergaard, 2008; Sell et al., 2004). PGC-1α coactivates 
transcription factor PPARγ bound to the rpomoters of target genes, such as UCP-1, to 
control gene transcription (Puigserver et al., 1998; Tiraby et al., 2003). The results show 
PRR activation suppressed both PPARγ mRNA and protein expression under the basal 
and isoproterenol-stimulated conditions whereas PRR activation only suppressed PGC-
1α mRNA under the basal condition, but did not suppress PGC-1α protein under both 
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conditions (Figure 7A and B). The differences between mRNA and protein expression of 
PGC-1α may be due to the protein stability. Moreover, we also examined the brown 
adipocyte cell morphology and lipid accumulation under the same conditions. Both the 
cell morphology (data not shown) and lipid accumulation by ORO staining and 
quantification (Figure 7C) did not seem to be affected by PRR activation. Taken 
together, our results demonstrate that PRR activation in differentiated brown adipocytes 
selectively suppressed UCP-1 and some other brown adipocyte markers expression 
(e.g., PPARγ and Cidea) without affecting mitochondrial biogenesis and lipid 
accumulation, which is sufficient to lead to suppressed mitochondrial oxygen 
consumption and uncoupled respiration. 
In summary, we have demonstrated the role of selected PRRs in mediating 
inflammation and downregulation of UCP-1 expression without affecting mitochondrial 
biogenesis and lipid accumulation, leading to suppressed mitochondrial respiration in 
the classical brown adipocytes. Our results suggest that PRR-mediated inflammation in 
brown adipocytes may be potential targets to modulate BAT function for obesity 
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Figure 1 mRNA expression of selected PRRs are up-regulated in brown fat tissue 
of DIO and ob/ob mice 
mRNA expression of NOD1, NOD2, TLR4 and TLR2 (A, B) and proinflammatory 
chemokines/cytokines (MCP-1, IL-6, RANTES, TNF-α) (C, D) in the interscapular brown 
fat tissue from the DIO male mice (n=7) (A, C) or ob/ob male mice (n=6), and their 
respective controls were evaluated by semi-quantitative RT-PCR. The relative mRNA 
expression was normalized to 36B4 and expressed as fold of the value of TLR2 in chow 
fed or wt group (set as 1). a-d are for Chow or WT groups (solid bars); a’-c’ are for DIO 
or Ob/Ob groups (gray bars). Different letters indicate significant differences among 





Figure 2 Expression of selected PRRs are up-regulated during brown adipocyte 
differentiation 
Brown fat cells were differentiated as described in Materials and Methods. Total RNA 
was isolated at confluency (D0), 2 (D2), 4 (D4), and 6 day (D6) post initiation of 
differentiation. (A) mRNA expression of NOD1, NOD2, TLR4, and TLR2 and brown 
adipocyte markers PGC-1α, PPARγ, and UCP-1 was evaluated by semi-quantitative 
RT-PCR. The relative mRNA expression was normalized to 36B4 and expressed as fold 
of D0 value (set as 1). (B) Relative mRNA expression of NOD1, NOD2, TLR4, and 
TLR2 before differentiation (D0) and after differentiation (D6) was compared. The 
relative mRNA expression was normalized to 36B4 and expressed as fold of NOD2 
value (set as 1). (C) Protein expression of NOD1, TLR4, and TLR2 was analyzed at D0, 
2, 4, and 6 by western analysis with primary antibodies against NOD1, TLR4, and 
TLR2. ERK1/2 protein was used as a loading control. This experiment has been 
performed independently three times, and the representative results are shown (left). 
Relative quantification of western analysis was done by densitometry. The data are 
expressed as fold to the D0 level (set as 1) (right). Data are means±SE (n=3). Different 
letters indicate significant differences between bars. *p<0.05, **p<0.01, significantly 





Figure 3 PRR activation in brown adipocytes induces phosphorylation and 
activation of NF-κB and MAPK signaling 
(A) Brown adipocytes were serum starved overnight and were stimulated with C12-
iEDAP (10 µg/ml), LPS (1 µg/ml), Pam3CSK4 (10 µg/ml) or the vehicle control for 
indicated times, and whole cell lysate was prepared and analyzed by western analysis 
with specific antibodies against phospho-p65, phospho-IκBα, phospho-p38, phospho-
JNK, phospho-ERK, p65, p38, JNK and ERK. (B) Brown adipocytes were infected with 
adenovirus encoded NF-κB-Luc and β-galactosidase for 24 h and stimulated with 
increasing doses of C12-iEDAP, LPS, or Pam3CSK4 as indicated for 18 h. Reporter 
gene assays were performed. Relative luciferase activities were normalized by β-
galactosidase activities for each sample and expressed as fold of the vehicle value (set 






Figure 4 PRR activation in brown adipocytes up-regulates the expression and 
secretion of proinflammatory cytokines/chemokines 
Brown adipocytes were stimulated with C12-iEDAP (10 µg/ml), LPS (0.1 µg/ml), 
Pam3CSK4 (1 µg/ml), or the vehicle control for 12 h. Total RNA was isolated for mRNA 
expression of MCP-1, IL-6, RANTES, TNF-α by semi-quantitative RT-PCR (A), and the 
supernatant was collected for protein measurements of MCP-1, IL-6, RANTES by 






Figure 5 Inhibition of NF-κB attenuates mRNA expression of proinflammatory 
cytokines/chemokines induced by PRR activation 
Brown adipocytes were pretreated with NF-κB inhibitor QNZ (20 nM) and CAPE (10 µM) 
for 1 h and costimulated with C12-iEDAP (10 µg/ml), LPS (0.1 µg/ml), Pam3CSK4 (1 
µg/ml), or the vehicle control. mRNA expression of MCP-1, IL-6, RANTES, and TNF-α 
was evaluated by semi-quantitative RT-PCR. The relative mRNA expression was 
normalized to 36B4 and expressed as fold of the vehicle value (set as 1). Data are 






Figure 6 Inhibition of MAPK differentially attenuates mRNA expression of 
proinflammatory cytokines/chemokines induced by PRR activation 
Brown adipocytes were pretreated with ERK inhibitor PD98054 (10 µM), JNK inhibitor 
SP600125 (10 µM), or p38 inhibitor SB203580 (2 µM) for 1 h and costimulated with 
C12-iEDAP (10 µg/ml), LPS (0.1 µg/ml), Pam3CSK4 (1 µg/ml) or the vehicle control. 
mRNA expression of MCP-1, IL-6, RANTES, and TNF-α was evaluated by semi-
quantitative RT-PCR. The relative mRNA expression was normalized to 36B4 and 
expressed as fold of the vehicle value (set as 1). Data are means±SE (n=3). *p<0.05, 




Figure 7 PRR activation suppresses both basal and isoproterenol-induced UCP-1 
expression, but not mitochondrial biogenesis, in brown adipocytes 
(A) Brown adipocytes were serum starved with 1% charcoal-dextran stripped FBS 
containing DMEM for overnight. The cells were pretreated with C12-iEDAP (10 µg/ml), 
LPS (0.1 µg/ml), Pam3CSK4 (1 µg/ml), or the vehicle control for 1 h followed by 
costimulated with or without isoproterenol (ISO, 1 µM) in the presence of the ligand for 6 
h. mRNA of UCP-1 and other marker genes was evaluated by semi-quantitative RT-
PCR. Relative gene expression was normalized to 36B4 and expressed as fold of the 
vehicle value (set as 1). (B, C) Brown adipocytes were serum starved overnight, and 
were treated with C12-iEDAP, LPS, and Pam3CSK4 for 12 h under the basal condition, 
or pretreated with C12-iEDAP, LPS, Pam3CSK4, or the vehicle control for 12 h, 
followed by costimulated with ISO in the presence of the ligand for another 6 h. Whole 
cell lysate was prepared from one set of cell samples and analyzed by western analysis 
with antibody against of UCP-1, PPARγ, and PGC-1α. ERK1/2 protein was used as a 
loading control. This experiment has been performed independently three times and the 
representative results are shown (left). Relative quantification of western analysis was 
done by densitometry. The data are expressed as fold to the level of the vehicle control 
(-) under basal condition (set as 1) (right). A duplicate set of cell samples were fixed and 
stained with oil red O (ORO) for lipid accumulation, and ORO absorbance at 500 nm is 
shown in C. (D) Brown adipocytes were subcultured and transiently transfected with 
mouse UCP-1-Luc together with β-galactosidase plasmid. The cells were pretreated 
with C12-iEDAP (10 µg/ml), LPS (0.1 µg/ml), Pam3CSK4 (1 µg/ml), or the vehicle 
control for 1 h followed by costimulation of the ligand with or without ISO for 15 h. 
Reporter gene assays were performed. Relative luciferase activities were normalized by 
β-galactosidase activities for each sample and expressed as fold of the vehicle value 
(set as 1). (E) Brown adipocytes were treated with C12-iEDAP (10 µg/ml), LPS (0.1 
µg/ml), Pam3CSK4 (1 µg/ml), or the vehicle control for 12 h. The cells were washed 
with PBS and stained with MitoTracker green (100 nM) for 30 min at 370C. The 
fluorescence intensities were measured as described in Materials and Methods. Data 










Figure 8 PRR activation suppresses mitochondrial respiration in brown 
adipocytes 
(A, B) Brown adipocytes were subcultured and seeded in 24-well XF assay plates 
overnight and were pretreated with LPS (0.1 μg/ml), Pam3CSK4 (1 μg/ml), C12-iEDAP 
(10 μg/ml), or the vehicle control for 12 h and were then subjected to real-time 
measurements of oxygen consumption rate (OCR) and extracellular acidification rate 
(ECAR). Following the basal measurements, all cells were injected either with the 
vehicle control or ISO (1 μM). In each experiment, mitochondrial complex inhibitors 
were injected to all treatments sequentially in the following order: oligomycin (1 μM), 
carbonyl cyanide-ptrifluoromethoxyphenylhydrazone (FCCP; 0.75 μM), antimycin 
A/rotenone (1 μM each), and the readings were taken after each inhibitor. The OCR (A) 
and ECAR (B) readings were plotted over time. Basal and ISO-induced OCR (C) and 
ECAR (D) is shown. ISO-induced maximal OCR (E), OCR from ATP production (F), 
OCR from proton leak (G), and coupling efficiency (H) are also shown. Data are 









CHRONIC ACTIVATION OF PATTERN RECOGNITION RECEPTORS 
SUPPRESSES BROWN ADIPOGENESIS OF MULTIPOTENT 




A version of this chapter was originally published by Jiyoung Bae, Jiangang 
Chen, Ling Zhao entitled “Chronic activation of pattern recognition receptors suppresses 
brown adipogenesis of multipotent mesodermal stem cells and brown pre-adipocytes” 





Brown adipose tissue (BAT) holds promise to combat obesity through energy-
spending, non-shivering thermogenesis. Understanding of regulation of BAT 
development can lead to novel strategies to increase BAT mass and function for obesity 
treatment and prevention. Here, we report the effects of chronic activation of PRR on 
brown adipogenesis of multipotent mesodermal stem C3H10T1/2 cells and immortalized 
brown pre-adipocytes from the classical interscapular BAT of mice. Activation of NOD1, 
TLR4, or TLR2 by their respective synthetic ligand suppressed brown marker gene 
expression and lipid accumulation during differentiation of brown-like adipocytes of 
C3H10T1/2. Activation of the PRR only during the commitment was sufficient to 
suppress the differentiation. PRR activation suppressed PGC-1α mRNA, but induced 
PRDM16 mRNA at the commitment. Consistently, PRR activation suppressed the 
differentiation of immortalized brown pre-adipocytes. Activation of PRR induced NF-κB 
activation in both cells, which correlated with their abilities to suppress PPARγ 
transactivation, a critical event for brown adipogenesis. Taken together, our results 
demonstrate that chronic PRR activation suppressed brown adipogenesis of multipotent 
mesodermal stem cells and brown pre-adipocytes, possibly through suppression of 
PPARγ transactivation. The results suggest that anti- inflammatory therapies targeting 





Obesity is one of the main public health concerns all over the world. Obesity is 
associated with chronic inflammation, which is considered to be the starting point for the 
progression of obesity associated comorbidities, such as insulin resistance and type 2 
diabetes. Evidence suggests that pattern recognition receptors (PRR) play critical roles 
in obesity associated inflammation (Jin et al. 2013). Toll-like receptors (TLR) and 
nucleotide-oligomerization domain containing protein-like receptor (NLR) are two 
families of PRRs that play critical roles in innate immune response and inflammation. 
TLRs are membrane-bound receptors, predominantly sensing microbe- or host-derived 
insults in the extracellular or endosomal compartments, whereas NLRs are cytosolic 
receptors, sensing invading intracellular pathogens and intracellular perturbations 
associated with stress or damage (Kawai and Akira 2009; Takeuchi and Akira 2010). 
TLRs are composed of extracellular leucine-rich repeat motifs and a cytoplasmic 
Toll/interleukin-1 receptor (TIR) homology domain. Out of the 10 and 12 functional TLRs 
identified in humans and mice, respectively, several TLRs, TLR4 and TLR2 in particular, 
have been implicated in adipose inflammation in diet-induced obesity (Shi et al. 2006; 
Tsukumo et al. 2007; Himes and Smith 2009; Ehses et al. 2010; Davis et al. 2011). 
NLRs are composed of a central nucleotide-binding domain, an N-terminal protein 
interaction domain, and a C-terminal leucine-rich repeat domain (Chen et al. 2009). 
NOD1 and NOD2 are two prominent members of NLRs. Activation of NOD1 has been 
shown to induce inflammation in white adipocytes (Zhao et al. 2011) and adipose 
inflammation and insulin resistance in mice (Schertzer et al. 2011). Activation of PRR 
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triggers proinflammatory signaling pathways, including NF-κB activation, leading to 
innate immune response in immune as well as non-immune cells. 
Brown adipose tissue (BAT) has gained increasing attention due to recent 
findings of brown fat depots in the cervical, supraclavicular, and paraspinal regions of 
adult humans (Cypess et al. 2009; Saito et al. 2009; van Marken Lichtenbelt et al. 2009; 
Virtanen et al. 2009; Zingaretti et al. 2009). In contrast to energy-storing role for white 
adipocytes, brown adipocytes are responsible for energy expenditure through non-
shivering thermogenesis. The thermogenic property of brown adipocytes is conferred 
mainly by the function of uncoupling protein 1 (UCP-1), uniquely expressed in the inner 
membrane of the enriched mitochondria to uncouple ATP synthesis from respiration, 
leading to heat production (Nicholls and Locke 1984; Ricquier 2005). Therefore, BAT 
has become a novel target for obesity treatment and prevention. Understanding of the 
regulation of BAT development by both positive and negative regulators hold great 
promise to lead to novel strategies to increase BAT mass and function to combat 
obesity (Vijgen and van Marken Lichtenbelt 2013; Vosselman et al. 2013). 
We have reported that TLR4, TLR2, and NOD1 are expressed and functional in 
BAT of mice and/or brown adipocytes (Bae et al. 2014). Acute activation of the PRR (< 
24hr) in mature brown adipocytes induces proinflammatory response, leading to 
suppression of UCP-1 expression and mitochondrial respiration. However, the effects of 
chronic activation of PRR on in vitro brown adipogenesis have not been studied. Here 
we report that the effects of chronic PRR activation on brown adipocyte differentiation 
using two well-studied cellular models of brown adipogenesis: multipotent mesodermal 
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stem C3H10T1/2 cells and brown pre-adipocytes derived from immortalized stromal 




3.3 Materials and methods 
Reagents 
Recombinant human bone morphogenic protein 4 (BMP4) was purchased from 
R&D Systems (Minneapolis, MN). NOD1 synthetic ligand lauroyl-γ-D-Glu-meso-
diaminopimelic acid (C12-iEDAP) and TLR2 ligand a synthetic triacylated lipoprotein 
Pam3CSK4 were purchased from Invivogen (San Diego, CA). Ultra pure TLR4 ligand 
lipopolysaccharide (LPS) was purchased from List Biological Laboratories (Campbell, 
CA). Fetal bovine serum (FBS) was purchased from Atlas Biologicals (Fort Collins, CO). 
Dulbecco’s modified Eagle’s medium (DMEM), 3-isobutyl-L-methylxanthine, T3, 
dexamethasone, insulin, indomethacin, and anti-UCP-1 antibody were purchased from 
Sigma-Aldrich (St. Louis, MO). Antibodies anti-ERK1/2 (#4695) and anti-PPARγ (#2443) 
were purchased from Cell signaling Technology (Danvers, MA). Anti-PGC-1 antibody 
(AB3242) was purchased from Millipore (Temecula, CA). Pharmacological inhibitor of 
NF-κB caffeic acid phenethyl ester (CAPE) was purchased from Tocris Bioscience 
(Ellisville, MI). 
Cell culture and brown differentiation 
Mouse multipotent mesodermal stem C3H10T1/2 cells were purchased from 
American Type Culture Collection (ATCC, Manassas, VA). Immortalized brown 
preadipocyte cell line, derived from the interscapular brown fat of 6-7 weeks old of 
C57BL mice, is a generous gift from Dr. Johannes Klein (University of Lubeck, 
Germany) (Klein et al. 2002). C3H10T1/2 cells were maintained in DMEM 
supplemented with 10% FBS (Atlas biological, Fort Collins, CO) and brown 
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preadipocytes were maintained in DMEM supplemented with 20% FBS. Both were 
grown at 37°C humidified atmosphere of 5% CO2 in air. 
The differentiation of brown-like adipocytes from C3H10T1/2 cells was essentially 
as described (Xue et al. 2014). C3H10T1/2 cells were plated into 20% confluence (day -
5 or D-5). On the second day, the cells were treated with BMP4 (20 ng/mL) for 5 days 
until they reach confluency (day 0 or D0). On D0, the cells were changed into DMEM 
supplemented with 20% FBS, 1 nM/L T3, 20 nM/L insulin, 0.125 mM/L indomethacin, 5 
μM/L dexamethasone, and 0.5 mM/L 3-isobutyl-L-methylxanthine for 24 h, followed by 
DMEM supplemented with 20% FBS, 1 nM/L T3, and 20 nM/L insulin, replenished every 
two days until the cells were fully differentiated at day 6 (D6). The differentiation of 
brown pre-adipocytes was as previously described (Bae et al. 2014). The cells were 
plated and grown in DMEM supplemented with 20% FBS until confluency (designed as 
D0). The cells were then changed into DMEM supplemented with 20% FBS, 1 nM/L T3, 
20 nM/L insulin, 0.125 mM/L indomethacin, 5 μM/L dexamethasone, and 0.5 mM/L 3-
isobutyl-L-methylxanthine for 24 h, followed by DMEM supplemented with 20% FBS, 1 
nM/L T3, and 20 nM/L insulin, replenished every two days until the cells were fully 
differentiated at day 6 (D6). 
The synthetic PRR ligand C12-iEDAP, LPS, Pam3CSK or the vehicle control was 
added to the media as indicated in the figures and figure legends. The ligands were 
replaced with each change of the media during the process, as indicated. 
Western blot analysis 
Total cell lysates were prepared and protein concentrations were determined by 
BCA assay kit (Thermo Scientific, Waltham, MA). Thirty micrograms of total cell lysates 
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were subjected to 10% SDS-PAGE and transferred to polyvinylidene difluoride 
membrane (Bio-Rad, Hercules, CA). The membrane was incubated with 5% nonfat milk 
blocking solution containing 20 mM/L Tris-HCl, 137 mM/L NaCl, and 0.1% Tween 20 
(pH 7.4). The membrane was immunoblotted with primary antibodies at 4°C for 
overnight followed by secondary antibody conjugated with horseradish peroxidase (GE 
Healthcare). The signals were developed by enhanced chemiluminescence method 
(Thermo Scientific, Rockford, IL). 
RNA preparation and quantitative real-time PCR analysis 
Total RNA was prepared using TRI reagent (Molecular Research Center, 
Cincinnati, OH). Total RNA abundance was quantified using a NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, Wilmington, DE). Reverse transcription 
was carried out using Fermentas first strand synthesis kit (Thermo Scientific, Pittsburgh, 
PA) according to the manufacturer’s instruction. mRNA expression of indicated genes 
and loading control 36B4 (an uncharacterized large riobosomal protein) gene were 
measured quantitatively using gene-specific primers, and PCR was run in a 96-well 
plate using an ABI 7300HT instrument. Cycle conditions were 50 0C 2min, 95 0C 15 min, 
then 40 cycles of 95 0C for 15 s/60 0C for 1 min. Relative gene expression was 
calculated using the 2-Ct method, which was normalized by loading control 36B4. 
Reporter gene assays 
Brown pre-adipocytes and C3H10T1/2 cells were transfected with PPARγ 
transactivation reporters, which contain a fusion of murine PPARγ ligand binding 
domain coupled to the Gal4 DNA binding domain (mPPARγ-Gal4), a reporter containing 
an upstream activating sequence (UAS)-linked luciferase (4xUAS-thymidine kinase-luc), 
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and β-galactosidase (β-gal) expression plasmid. PPARγ transactivation reporters were 
a gift from Dr. Susanne Mandrup at University of Southern Denmark, Denmark. The 
cells were then pre-treated with C12-iEDAP, LPS, Pam3CSK or the vehicle control for 2 
h and then co-treated with or without PPARγ ligand rosiglitazone (Rosi, 0.5 μM/L) for 15 
h. In some cases, the cells were pre-treated with NF-κB inhibitor CAPE or the vehicle 
DMSO for 2 h before the PRR ligand was added, or the cells were infected with 
adenovirus that encodes IκBα super-repressor (SR) or the control virus encodes β-gal 
for 24 h before being transfected with PPARγ transactivation reporters. For NF-κB 
activation experiments, C3H10T1/2 cells were infected with adenovirus encoding NF-
κB-Luc reporter gene for 24 h. The cells were then stimulated with C12-iEDAP, LPS, 
Pam3CSK4, or the vehicle control for 15 h. The cell lysate was prepared and reporter 
luciferase and β-gal activities were measured with GloMax Luminometer (Promega, 
Madison, WI). 
Oil red O staining and quantification 
Differentiated brown adipocytes and C3H10T1/2 cells were fixed with 4% 
formaldehyde solution overnight, and lipid accumulation were stained with oil red O 
(ORO) and quantified by absorbance at 500 nm in a spectrophotometer.  
Statistical analysis 
All data were presented as means ± SE. Measurements were performed in 
triplicates. Data were Log transformed when appropriate. Statistical analysis was 
performed using SigmaPlot 12.0 (Systat Software, Inc.). One way ANOVA with repeated 
measures followed by multiple comparisons test (Student-Newman-Keuls Method) were 
performed to determine the differences between the treatment groups and/or time 
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points. Student’s t-test was performed when appropriate. The level of significance was 





mRNA expression and functionality of PRR during commitment and 
differentiation of brown-like adipocyte of multipotent mesodermal stem 
C3H10T1/2 cells   
We examined mRNA expression of selected PRRs, NOD1, NOD2, TLR4 and 
TLR2 in C3H10T1/2 cells after plating (D-5), commitment (D0), and differentiation (D6) 
to brown-like adipocytes, as shown in Figure 9A. mRNA of all examined PRR was 
significantly up-regulated during commitment and then down-regulated during the 
differentiation phase (Figure 9A), leading to a higher mRNA expression for NOD1 and 
TLR4 (p<0.05) and no changes of mRNA expression for NOD2 and TLR2 in brown-like 
adipocytes (Figure 9A). Comparisons among the PRRs show that TLR4 mRNA 
expression was the highest, followed by NOD1 and TLR2, and NOD2 mRNA expression 
was the lowest after the cells were plated at D-5 (Figure 9B). Similar patterns were 
maintained through commitment (D0) and differentiation (D6) (Figure 9B).  
We examined the functionality of the selected PRRs by NF-κB activation assays.  
Except for NOD2 ligand MDP (data not shown), the synthetic ligand of NOD1 (C12-
iEDAP), TLR4 (LPS), and TLR2 (Pam3CSK4) induced robust NF-κB activation in 
C3H10T1/2 cells (p<0.001) (Figure 9C). Taken together, these results indicate that 





Chronic activation of NOD1, TLR4, or TLR2 suppresses brown-like adipocyte 
differentiation of C3H10T1/2 cells 
We next examined the effects of chronic activation of NOD1, TLR4, or TLR2 on 
brown-like adipocyte differentiation of C3H10T1/2 cells in the presence or absence of 
their respective synthetic ligand, as shown in Figure 10A. More than 95% of C3H10T1/2 
cells were differentiated into brown-like adipocytes at D6 after being committed by 
BMP4 and differentiated as previously reported (Xue et al. 2014). The presence of the 
synthetic ligand of NOD1, TLR4, or TLR2 during both the commitment and 
differentiation phases significantly suppressed the differentiation of brown-like 
adipocytes, as revealed by the paucity of oil red O stained multilocular, lipid-filled brown 
adipocytes (Figure 10B), decreased lipid accumulation (Figure 10C), and almost 
completely abolished protein expression of established brown adipocyte marker PPARγ, 
PGC-1α, and UCP-1, compared with the controls (Figure 10D). 
Analysis of mRNA further revealed that mRNA expression of PPARγ, PGC-1α, 
and UCP-1 was consistent with the protein expression (Figure 11A). mRNA expression 
of PR domain containing 16 (PRDM16), a zinc-finger binding protein recently identified 
as an early regulator for brown cell fate (Seale et al. 2007), was also significantly 
suppressed (p<0.01) (Figure 11A). In addition, of the two transcription factors regulating 
mitochondrial gene expression, mRNA expression of nuclear respiratory factor 1 (Nrf-1) 
(p<0.05 for NOD1 and TLR2, p<0.01 for TLR4), but not transcription factor A (Tfam), 
was down-regulated by the PRR activation (Figure 11B). Consequently, mRNA 
expression of the two nucleus-encoded mitochondrial genes, cytochrome b-c1 complex 
subunit 6 (Uqcrh) (p<0.05) and cytochrome c oxidase subunit IV a (Cox4a) (p<0.01) 
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were also down-regulated by the PRR activation (Figure 11B). Taken together, these 
results suggest that PRR activation suppresses brown-like differentiation, including 
mitochondrial biogenesis, of C3H10T1/2 cells. 
Differential regulation of the novel brown and white adipocyte-specific markers 
by chronic PRR activation in C3H10T1/2 cells 
The transcriptome analysis (Timmons et al. 2007) and a global transcription 
factor screen (Seale et al. 2007) have identified differences in the transcription factor 
profiles between brown and white adipocytes. To examine whether PRR activation 
could modulate brown versus white adipocyte fate, we examined the mRNA expression 
of novel brown transcription factor zinc finger protein of the cerebellum 1 (Zic1), LIM 
homeobox protein 8 (Lhx8), and mesenchyme homeobox 2 (Meox2), and white specific 
marker insulin-like growth factor-binding protein 3 (IGFBP3) and homeo box C9 (Hoxc9) 
at D6 in C3H10T1/2 cells. Activation of TLR4, but not NOD1 or TLR2, significantly 
suppressed novel brown marker Zic1 mRNA expression (p<0.05) (Figure 11C). In 
contrast, NOD1 activation significantly up-regulated mRNA expression of Lhx8 and 
Meox-2 (p<0.01), which were not affected by the activation of TLR4 or TLR2 (Figure 
11C). Moreover, activation of NOD1 and TLR4, but not TLR2, significantly up-regulated 
mRNA expression of white specific IGFBP3 (p<0.05), whereas activation of NOD1, 





PRR activation only during the commitment phase is sufficient to lead to 
suppression of differentiation of brown-like adipocytes of C3H10T1/2 cells 
The commitment of multipotent stem cells into either white or brown adipocytes 
has been a focus of recent studies. The commitment of C3H10T1/2 cells into brown-like 
adipocytes is positively regulated by bone morphogenic proteins (BMPs) (Tseng et al. 
2008; Xue et al. 2014). We examined whether activation of NOD1, TLR4, or TLR2 only 
during the commitment is sufficient enough to lead to suppression of differentiation of 
brown-like adipocytes of C3H10T1/2. C3H10T1/2 cells were committed towards brown-
like adipocytes with BMP4 in the presence or absence of the PRR synthetic ligand until 
the cells reach confluency, followed by the induction to differentiation, as shown in 
Figure 12A. Activation of NOD1, TLR4, or TLR2 only during the commitment was 
sufficient to suppress differentiation of brown-like adipocytes of C3H10T1/2 cells, 
although to a lesser degree, as revealed by paucity of the oil red O stained multilocular, 
lipid-filled brown-like adipocytes (Figure 12B), decreased lipid accumulation (Figure 
12C), and attenuated protein expression of PPARγ, PGC-1α, and UCP-1 at D6, 
compared with the controls (Figure 12D). 
Analysis of mRNA of established brown marker PPARγ, PGC-1α, and UCP-1 
was consistent with the protein expression (Figure 13A). Notably, PRDM16 mRNA was 
not suppressed at D6 when PRR activation only occurred during the commitment 
(Figure 13A). Activation of NOD1, TLR4, or TLR2 during commitment suppressed 
mRNA expression of Uqcrh (p<0.01) and Cox4a (p<0.05), whereas mRNA expression 
of Tfam and Nrf-1 was not suppressed at D6 (Figure 13B). Moreover, only Zic-1 mRNA 
expression was suppressed by TLR4 activation (p<0.05), and mRNA expression of 
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Lhx8 or Meox-2 was not altered at D6 (Figure 13C). Further, activation of NOD1 or 
TLR4, but not TLR2, during commitment induced IGFBP3 mRNA, whereas none of the 
activation altered Hoxc9 mRNA at D6 in C3H10T1/2 cells (Figure 13D). 
Activation of PRR suppresses the commitment to brown-like adipocytes of 
C3H10T1/2 cells 
To gain insights into the effects of PRR activation on commitment, we further 
examined the changes in mRNA expression by PRR activation at the commitment. 
C3H10T1/2 cells were committed towards brown-like adipocytes with BMP4 in the 
presence or absence of the PRR synthetic ligand until the cells reach confluency (D0), 
as shown in Figure 14A. Activation of NOD1, TLR4, or TLR2 significantly suppressed 
mRNA expression of PGC-1α (p<0.01), but not PPARγ at the commitment (Figure 14B). 
Surprisingly, activation of NOD1 and TLR4, but not TLR2, significantly induced up-
regulation of PRDM16 (p<0.05) (Figure 14B). No significant change was noted for Tfam, 
Nrf-1, Uqcrh, and Cox4a at the commitment (data not shown). Moreover, activation of 
NOD1, TLR4, or TLR2 significantly suppressed mRNA expression of Zic1, Lhx8, and 
Meox-2 and white specific marker Hoxc9 (Figure 14C). In contrast, no changes of 
IGFBP3 mRNA were noted by the activation of NOD1 and TLR4, but it was induced by 
TLR2 activation (p<0.05) (Figure 14D). 
Chronic activation of NOD1, TLR4, or TLR2 suppresses terminal differentiation of 
immortalized brown pre-adipocytes derived from BAT of mice 
To validate the effects of chronic PRR activation on multipotent stem cells, we 
further examined the effects of PRR activation on terminal brown differentiation from 
immortalized brown pre-adipocytes derived from classical BAT of C57BL6 mice. We 
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have previously shown that NOD1, TLR4, and TLR2 were expressed and functional in 
these cells (Bae et al. 2014). Brown pre-adipocytes were differentiated in the presence 
or absence of the synthetic ligand during the differentiation, as shown in Figure 15A. 
Activation of NOD1, TLR4, or TLR2 suppressed brown adipocyte differentiation 
compared to the control, as revealed by the paucity of oil red O stained multilocular, 
lipid-filled brown adipocytes (Figure 15B), reduced lipid accumulation (Figure 15C), and 
attenuated protein expression of brown-specific marker PPARγ, PGC-1α, and UCP-1 
(Figure 15D) at D6. Analysis of mRNA showed that activation of NOD1, TLR4, or TLR2 
also suppressed mRNA expression of PPARγ, PGC-1α, PRDM16, and UCP-1 (p<0.01) 
(Figure 15E). Moreover, mRNA expression of nucleus-encoded mitochondrial gene 
Uqcrh and Cox4a was suppressed by the examined PRR (p<0.01); however, only TLR4 
activation significantly suppressed mRNA expression of Tfam and Nrf-1 at D6 (p<0.01) 
(Figure 15F). 
Activation of PRR suppresses PPARγ transactivation through NF-κB pathway 
To explore molecular mechanisms by which activation of NOD1, TLR4, or TLR2 
suppressed brown adipocyte differentiation, we examined whether activation of NOD1, 
TLR4, or TLR2 affects PPARγ transactivation, the key event for brown adipocyte 
differentiation, using PPARγ transactivation reporters. Activation of NOD1, TLR4, or 
TLR2 suppressed PPARγ ligand rosiglitazone (Rosi)-induced PPARγ transactivation in 
C3H10T1/2 cells, which was reversed by the specific NF-κB inhibitor CAPE (Figure 
16A), and IκB super-repressor (IκB(SR)) (Figure 16B), which contains two amino acid 
substitutions (S32A/S36A) that prevent phosphorylation and degradation of the protein 
and blocks the activation of NF-κB in response to proinflammatory stimulations (Jobin et 
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al. 1998). Similarly, activation of NOD1, TLR4, or TLR2 also suppressed Rosi-induced 
PPARγ transactivation in brown pre-adipocytes, which was reversed by NF-κB inhibitor 
CAPE (Figure 16D) and IκB(SR) (Figure 16E). Consistently, suppression of brown-like 
adipocyte differentiation of C3H10T1/2 cells by PRR activation during the commitment 
was reversed by NF-κB inhibitor CAPE, compared to the vehicle control, as revealed by 





PRR-mediated inflammation has been implicated in adipose inflammation and 
obesity. In current studies, we demonstrate, for the first time, that chronic activation of 
selected PRR leads to suppression of brown adipogenesis of multipotent stem cells and 
committed brown pre-adipocytes, suggesting that PRR activation negatively impacts 
BAT development. Our results have revealed a new role of PRR-mediated inflammation 
in the development of obesity. 
The C3H10T1/2 line is the best characterized mesodermal multipotent stem cell 
line that faithfully mimic multipotent stem cells in vivo and can be induced to undergo 
commitment and differentiation to the muscle, bone, cartilage, and adipose lineage 
(Taylor and Jones 1979; Konieczny and Emerson 1984; Gregoire et al. 1998; Shin et al. 
2000; Mikami et al. 2011; Tang and Lane 2012). The genetic mapping studies have 
revealed that brown adipocytes and muscle, but not white adipocytes, were derived 
from Myf-5 expressing precursor cells (Seale et al. 2008). The transcription factor 
PRDM16 was shown to act as a switch to drive differentiation of the Myf-5 expressing 
stem cells into brown adipocytes. Knockdown of PRDM16 in the precursor cells resulted 
in loss of brown fat characteristics, leading to muscle cell phenotype, while over-
expression of PRDM16 in white pre-adipocytes or myoblasts resulted in brown 
adipocyte phenotype (Seale et al. 2008). 
It has been reported that BMPs, members of transforming growth factor-β (TGFβ) 
superfamily, play critical roles in the commitment and differentiation of brown-like 
adipocytes from C3H10T1/2 cells. It has been demonstrated that pre-treatment of BMP4 
at 20 ng/ml during proliferation produced clonal lines that were capable of differentiating 
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into brown-like adipocytes when subjected to brown differentiation inducers without 
exogenous BMP4 and into brown-like fat when implanted into athymic nude mice (Xue 
et al. 2014). BMP4 pre-treatment was shown to induce up-regulation of PRDM16, 
leading to the commitment of C3H10T1/2 cells into brown preadipocytes (Xue et al. 
2014).  
Effects of PRR activation on commitment and differentiation 
We have used C3H10T1/2 line to gain insights into the effects of chronic PRR 
activation on commitment and differentiation of brown-like adipocytes from mesodermal 
stem cells. Our results demonstrate that chronic activation of selected PRR during both 
the commitment and differentiation suppressed the brown-like adipogenesis of 
C3H10T1/2 cells, as revealed by paucity of oil red O stained, multilocular brown 
adipocyte morphology and suppressed gene expression of brown specific markers, and 
lipid accumulation. It should be noted that, although to a lesser degree, compared to 
that of PRR activation in both the commitment and differentiation phase, PRR activation 
only during the commitment phase was sufficient enough to suppress brown-like 
differentiation of C3H10T1/2 cells. Gene expression analysis revealed that PRR 
activation during commitment suppressed mRNA expression of PGC-1α, but not PPARγ 
or PRDM16, at the commitment. In fact, there was no change of PPARγ mRNA, 
whereas PRDM16 mRNA was significantly up-regulated by activation of NOD1 and 
TLR4, but not TLR2. PPARγ, PGC-1α, and PRDM16 are considered to be the core 
regulators for brown differentiation (Richard and Picard 2011; Satterfield and Wu 2011; 
Harms and Seale 2013). Studies have shown that PRDM16 acts primarily through 
binding to and modulating the activities of other transcription factors, including 
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CCAAT/enhancer binding protein beta (C/EBPβ) (Kajimura et al. 2008), PPARγ (Seale 
et al. 2008), and PGC-1α (Seale et al. 2007). PPARγ is the transcription factor that not 
only regulates white adipocyte differentiation, but also brown adipocyte differentiation 
(Rosen et al. 1999; Imai et al. 2004). PGC-1α is a co-activator for PPARγ. Activation of 
PPARγ and PGC-1α subsequently up-regulate a number of genes involved in brown 
adipocyte differentiation and function, including UCP-1 (Richard and Picard 2011; 
Harms and Seale 2013). In addition, PGC-1α has been shown to control mitochondrial 
biogenesis through induction of uncoupling proteins and regulation of nuclear 
respiratory factors (Wu et al. 1999). Our results demonstrate that PRR activation during 
the commitment leads to suppression of brown-like differentiation, characterized by 
suppressed mRNA expression of established brown marker PPARγ, PGC-1α, and UCP-
1, but not PRDM16, possibly through modulation of early events in the commitment, 
such as more upstream transcription factors, and epigenetic changes, which directly or 
indirectly suppressed the core regulators, leading to the suppression of brown-like 
differentiation. Further PRR activation during the differentiation leads to more robust 
suppression of differentiation, characterized by suppression of almost all brown specific 
markers, including PRDM16.  
Effects of PRR activation on novel brown and white specific markers: To whiten it 
or not? 
To our knowledge, this is the first report of PRR activation on novel brown versus 
white specific markers in brown-like differentiation of C3H10T1/2 cells. Identification of 
novel brown and white specific markers has provided molecular insights into the 
characterization of brown, white, and beige adipocytes. It has been reported that 
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chronic treatment with the PPARγ agonist rosiglitazone induced browning of 
epididymally derived white adipocyte cultures with norepinephrine-inducible UCP-1 
gene expression and thermogenic capacity. These cells were characterized with low 
mRNA expression of Zic-1, Lhx8, and Meox2, novel transcription factors now 
associated with classic brown adipocytes (Timmons et al. 2007), decreased white 
adipocyte specific IGFBP3, but retained white specific Hoxc9 expression (Petrovic et al. 
2008). We show that selected PRR activation during both commitment and 
differentiation differentially modulated novel brown specific markers. TLR4 activation 
suppressed Zic1 mRNA, which was not affected by the activation of NOD1 or TLR2, 
whereas NOD1 activation significantly induced mRNA of Lhx8 and Meox2, which were 
not affected by activation of TLR4 or TLR2. In contrast, activation of NOD1 and TLR4, 
but not TLR2, significantly induced white specific IGFBP3 mRNA and no significant 
changes in Hoxc9 were observed. Only the suppression of Zic1 by TLR4 activation and 
induction of IGFBP3 by NOD1 and TLR4 remained when the PRR activation only 
occurred in the commitment phase. Together, our results suggest that activation of PRR 
differentially modulate brown versus white marker gene expression in the stem cell 
differentiation. It remains to be determined whether activation of certain PRR, TLR4 in 
particular, induces “whitening” in brown-like adipocytes differentiated from C3H10T1/2.  
Further characterization of the role of each of these novel brown and white specific 
marker genes in controlling brown versus white cell fate will provide new insights into 





Mechanisms of chronic PRR activation on brown differentiation  
It has been shown that activation of NOD1 (Purohit et al. 2012) or TLR4 (Song et 
al. 2006) suppressed 3T3-L1 white adipocyte differentiation. Activation of NOD1 
induced NF-κB activation in 3T3-L1 cells, which correlated with the suppression of 
ligand-induced PPARγ activation (Purohit et al. 2012). It has been demonstrated that 
NOD1, TLR4, and TLR2 are expressed and functional in brown adipocytes (Bae et al. 
2014). Here, we show that these PRRs are expressed and functional in C3H10T1/2 
cells. Moreover, we show that activation of NOD1, TLR4, or TLR2 suppressed PPARγ 
transactivation, which was reversed by the pharmacological inhibitor of NF-κB (CAPE) 
and IκBα super-repressor (IκB (SR)) in both cell types. Further, we show NF-κB 
inhibition by CAPE attenuated suppression of brown-like differentiation by PRR 
activation, indicated by the oil red O stained lipid accumulation. Together, the results 
suggest that suppression of brown adipogenesis by PRR activation is at least in part 
mediated through suppression of PPARγ transactivation by NF-κB pathway. 
In conclusion, we have demonstrated the suppressive effects of chronic 
activation of selected PRR on brown adipogenesis of multipotent mesodermal stem 
C3H10T1/2 cells and immortalized brown preadipocytes. Our results suggest that 
suppression of brown differentiation could, at least in part, be mediated by suppression 
of PPARγ transactivation via NF-κB pathway, and anti-inflammatory therapies targeting 
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Figure 9 Selected PRRs are expressed and functional during commitment and 
differentiation of multipotent mesodermal stem C3H10T1/2 cells 
C3H10T1/2 cells were committed with BMP4 for 5 days until confluency, and then were 
differentiated into brown-like adipocytes for another 6 days, as shown in the diagram. 
Total RNA were collected at after plating (D-5), commitment (D0), and differentiation 
(D6) according to the diagram. (A, B) mRNA expression of PRRs were evaluated by 
semi-quantitative RT-PCR (A), and relative mRNA expression of PRRs at D-5, D0, and 
D6 were compared (B). The relative mRNA expression was normalized to 36B4 and 
expressed as fold of NOD2 value or D-5 value (set as 1). (C) Functionality of the 
selected PRRs was measured by NF-κB reporter assays. Data are mean±SE (n=3). 
Different letters indicate significant differences between bars. , significantly different 









Figure 10 Chronic activation of NOD1, TLR4, or TLR2 suppresses brown-like 
adipocyte differentiation of C3H10T1/2 cells 
C3H10T1/2 cells were committed and differentiated into brown-like adipocytes the 
presence of C12-iEDAP (10 µg/ml), LPS (1 µg/ml), Pam3CSK4 (10 µg/ml), or the 
vehicle control, as shown in (A). ORO stained cell morphology (B) and ORO 
absorbance (C) are shown. (D) Protein expression of established brown specific marker 
PPARγ, PGC-1α, and UCP-1 at D6 were analyzed by western blot. ERK1/2 is shown as 






Figure 11 Molecular insights into the mechanisms by which chronic PRR 
activation suppresses brown-like differentiation of C3H10T1/2 
C3H10T1/2 cells were committed and differentiated into brown-like adipocytes in the 
presence of C12-iEDAP (10 µg/ml), LPS (1 µg/ml), Pam3CSK4 (10 µg/ml), or the 
vehicle control. mRNA expression of established brown markers PPARγ, PGC-1α, 
PRDM16, and UCP-1 (A); mitochondrial transcription factors, Tfam and Nrf-1, and 
structural genes, Uqcrh and Cox4a (B); novel brown transcription factors, Zic-1, Lhx8, 
and Meox-2 (C); and white specific markers IGFBP3 and Hoxc9 (D) at D6 are shown. 
The relative gene expression was normalized to 36B4 gene. Data are mean±SE (n=3). 





Figure 12 PRR activation only during the commitment phase is sufficient to lead 
to suppression of brown-like differentiation of C3H10T1/2 cells 
C3H10T1/2 cells were committed with BMP4 in the presence of C12-iEDAP (10 µg/ml), 
LPS (1 µg/ml), Pam3CSK4 (10 µg/ml), or the vehicle control and then differentiated into 
brown-like adipocytes without PRR ligands until D6, as shown in (A). ORO stained cell 
morphology (B) and ORO absorbance (C) were measured. (D) Protein expression of 
established brown specific marker PPARγ, PGC-1α, and UCP-1 at D6 were analyzed by 
western blot. ERK1/2 is shown as a loading control. Data are mean±SE (n=3). **, 





Figure 13 Molecular insights into the mechanisms by which PRR activation only 
during the commitment suppresses brown-like differentiation of C3H10T1/2 cells 
C3H10T1/2 cells were committed with BMP4 in the presence of C12-iEDAP (10 µg/ml), 
LPS (1 µg/ml), Pam3CSK4 (10 µg/ml), or the vehicle control and then differentiated into 
brown-like adipocytes without PRR ligands until D6. mRNA expression of established 
brown markers (A); mitochondrial biogenesis markers (B); novel brown markers (C); 
and white specific markers (D) at D6 are shown. The relative mRNA expression was 
normalized to 36B4 and expressed as fold of the control (set as 1). Data are mean±SE 






Figure 14 PRR activation suppresses the commitment to brown-like adipocytes of 
C3H10T1/2 cells 
C3H10T1/2 cells were committed towards brown-like adipocytes with BMP4 in the 
presence of the C12-iEDAP (10 µg/mL), LPS (1 µg/mL), Pam3CSK4 (10 µg/mL), or the 
vehicle control until the cells reach confluency, as shown in (A). mRNA expression of 
established brown markers (B), novel brown markers (C), and white specific markers 
(D) at D0 are shown. The relative mRNA expression was normalized to 36B4 and 
expressed as fold of the control (set as 1). Data are mean±SE (n=3). *, **, significantly 




Figure 15 Chronic activation of NOD1, TLR4, or TLR2 suppresses terminal 
differentiation of immortalized brown preadipocytes derived from BAT of mice 
Brown pre-adipocytes were differentiated in the presence of C12-iEDAP (10 µg/mL), 
LPS (1 µg/mL), Pam3CSK4 (10 µg/mL), or the vehicle control, as shown in (A). ORO 
stained cell morphology (B) and ORO absorbance (C) were measured. (D) Protein 
expression of established brown markers was analyzed by western blot. ERK1/2 is 
shown as a loading control. (E, F) mRNA expression of brown specific markers (E) and 
mitochondrial biogenesis markers (F) were analyzed at D6. The relative mRNA 
expression was normalized to 36B4 and expressed as fold of the control (set as 1). 








Figure 16 Activation of PRR suppresses PPARγ transactivation through NF-κB 
pathway 
(A, B, D, E) PPARγ transactivation reporters were transfected into C3H10T1/2 (A, B) 
and brown pre-adipocytes (D, E). The cells were pretreated with NF-κB inhibitor CAPE 
or DMSO (A, D) or infected with adenovirus that encodes IκB supper-repressor IκB(SR) 
or the control virus (B, E) before the addition of selected PRR ligands and PPARγ 
synthetic ligand rosiglitazone (Rosi, 0.5 µM) together with the inhibitor or DMSO in A 
and D for 15 h. Cell lysate was prepared and reporter assays were performed. PPARγ 
transactivation normalized by the luciferase activities is presented as fold of that of the 
controls (set as 1). (C) C3H10T1/2 cells were committed with BMP4 in the presence of 
the PRR ligand and NF-κB inhibitor CAPE or DMSO during the commitment and then 
differentiated into brown-like adipocytes without PRR ligand and the inhibitor until D6, 
as shown in the diagram. ORO absorbance was measured. Data are mean±SE (n=3). 





NARINGENIN, A CITRUS FLAVANONE, ENHANCES ISOPROTERENOL 
STIMULATED THERMOGENIC ACTIVATION OF 3T3-L1 ADIPOCYTES 
VIA PKA/P38 PATHWAYS 
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A version of this chapter will be submitted by Jiyoung Bae, Jiangang Chen, Ling 
Zhao entitled “Naringenin, a citrus flavanone, enhances isoproterenol stimulated 





Promoting thermogenesis through increasing the activities of functional brown 
adipose tissues (BAT) has promised new hope for obesity treatment and prevention. 
Naringenin is an abundant flavanone mainly found in citrus fruits. Emerging evidence 
suggests that naringenin has anti-inflammatory and anti-oxidant properties and is 
beneficial in obesity and obesity related chronic diseases. Recently, naringenin has 
been reported to be capable of activating nuclear receptors, including PPAR gamma; 
however, it is not clear whether naringenin promotes activities of functional BAT, similar 
to what has been reported for rosiglitazone, a synthetic ligand for PPAR gamma. Here, 
we investigated the effects of naringenin on browning and isoproterenol-stimulated 
thermogenic activation of 3T3-L1 adipocytes. 3T3-L1 cells were differentiated into 
mature adipocytes with standard differentiation cocktail in the presence or absence of 
naringenin, followed by stimulation with β-adrenergic agonist isoproterenol. Although 
naringenin did not increase UCP-1 mRNA at basal condition, it significantly increased 
the isoproterenol-stimulated upregulation of UCP-1 and PGC-1α mRNA expression and 
enhanced isoproterenol-stimulated thermogenesis. Moreover, naringenin enhanced 
activation of PKA and phosphorylation of p38 MAPK downstream of isoproterenol 
stimulation; and inhibition of either PKA or p38 by their respective pharmacological 
inhibitors blocked naringenin-induced upregulation of UCP-1 mRNA. Taken together, 
our results demonstrate that naringenin enhances isoproterenol-induced thermogenic 




Obesity has been a growing problem across the globe over the past few 
decades, and if untreated, leads to metabolic disorders. Two types of adipose tissues, 
white adipose tissue (WAT) and brown adipose tissue (BAT), contribute to energy 
storage and expenditure. Results from recent animal and human studies, however, 
have identified inducible brown-like adipocytes, also known as beige adipocytes, in 
WAT (Giralt & Villarroya, 2013; Lo & Sun, 2013; A. Park, Kim, & Bae, 2014; J. W. Park 
et al., 2015; Rosenwald & Wolfrum, 2014). When exposed to cold temperature, 
hormonal stimuli (e.g. irisin and T3) (Obregon, 2014a; Zhang et al., 2014), or 
pharmacological treatment (e.g. rosiglitazone, bone morphogenetic protein, and 
isoproterenol) (Elsen et al., 2014; Obregon, 2014b; J. Wu et al., 2012), beige adipocytes 
can adopt a brown adipocyte phenotype via browning with increased UCP-1 expression, 
contributing to thermogenesis and energy expenditure.  
Naringenin (4’,5,7-trihydroxyflavanone), a citrus flavanone found in grapefruit, 
has emerged as a dietary bioactive compound with myriads of beneficial effects (Alam 
et al., 2014; Assini et al., 2013; Coelho, Hermsdorff, & Bressan, 2013; E Orhan et al., 
2015; Mir & Tiku, 2015; Sharma et al., 2015). For example, several studies have 
reported anti-inflammatory properties of naringenin in various cell/disease models 
(Chtourou et al., 2015; H. Y. Park, Kim, & Choi, 2012; Seyedrezazadeh et al., 2015; Shi 
et al., 2009; L.-H. Wu et al., 2015; Yu, Ma, Yue, Yao, & Mao, 2015). 
It has been reported that oral administration of naringenin in rodents decrease 
WAT adipose mass (Assini et al., 2013; Ke et al., 2015), reduce adipose tissue 
inflammation (Ke et al., 2015; Hiroki Yoshida et al., 2014; H. Yoshida et al., 2013) and 
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macrophage infiltration (Hiroki Yoshida et al., 2014) in high-fat induced obesity. 
Naringenin suppressed Toll-like receptor 2 (TLR2) expression induced by TNFα and 
high fat feeding (H. Yoshida et al., 2013). Recently, naringenin has been reported to 
activate nuclear receptors, including PPARγ (Goldwasser et al., 2010). PPARγ agonist 
rosiglitazone induced “browning” in primary culture derived from subcutaneous white fat 
(Petrovic et al., 2010) and induced UCP-1 expression and thermogenesis (Petrovic, 
Shabalina, Timmons, Cannon, & Nedergaard, 2008). However, it is not clear whether 
naringenin has such effects. 
In this report, we investigated the impact of naringenin treatment on browning 
and thermogenic activation by isoproterenol, a β-adrenergic receptor agonist, in 3T3-L1 
adipocytes. We report naringenin at 10 μM significantly promoted the isoproterenol-
stimulated upregulation of UCP-1 and PGC-1α mRNA expression and thermogenesis in 
the 3T3-L1 adipocytes. We further demonstrated the effects by naringenin are mediated 




4.3 Materials and Methods 
Reagents 
Murine 3T3-L1 cells were obtained from ATCC (Manassas, VA). Naringenin, 
Dulbecco’s modified Eagle’s medium (DMEM), 3-Isobutyl-L-methylxanthine, 
dexamethasone, insulin, isoproterenol (ISO), and rosiglitazone (Rosi) were from Sigma 
(St. Louis, MO). Calf serum (CS) was purchased from Hyclone (Logan, UT) and fetal 
bovine serum (FBS) was purchased from Atlas Biologicals (Fort Collins, CO). The 
pharmacological inhibitors for p38 (SB203580) and PKA (H-89) were from Tocris 
Bioscience (Ellisville, MI). Anti-phospho-p38 (Thr180/Tyr182) (no. 9211), anti-p38 (no. 
9212) antibodies, and horseradish peroxidase-conjugated goat anti-rabbit were from 
Cell Signaling Technology (Danvers, MA).  
Naringenin was dissolved in dimethyl sulfoxide (DMSO, Sigma, St. Louis, MO) to 
make 50 mM concentration followed by dilution in DMSO to make 0, 5 and 10 mM for 
treatment. The final DMSO concentration in cell culture medium was ≤ 0.1%. 
Cell culture and treatment 
Murine 3T3-L1 cells were grown in DMEM supplemented with 10% CS at 37°C 
humidified atmosphere of 5% CO2 in air until they reached confluence [designated as 
day 0 (D0)]. The cells were differentiated in DMEM containing 10% FBS, 1 μM/L 
dexamethasone, 0.5 mM/L 3-isobutyl-1-methylxanthine (IBMX) and 10 μg/mL insulin 
(Cohen et al.) for 3 days, followed by treatment with 10 μg/mL insulin in DMEM 
containing 10% FBS for an additional 2 days. The cells were then maintained in DMEM 
containing 10% FBS until fully differentiated at day 7 (D7).  
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To examine the effects of naringenin on browning of 3T3-L1 adipocytes, 
confluent 3T3-L1 cells were differentiated with DMI in the presence or absence of 
various doses of naringenin starting on D0 as indicated in the figure legends. Fresh 
naringenin was replaced at each change of the media during the entire differentiation 
process. Rosi (1 μM) was used as a positive control. On D7, the cells were stimulated 
with Isoproterenol (ISO, 1 µM) or the vehicle control for 6 h. Pharmacological inhibitors, 
SB203580 and H-89, were applied one hour before the ISO stimulation as indicated in 
the figure legends.  
PKA activity 
On D7, 3T3-L1 adipocytes differentiated in the presence or absence of 
naringenin (10 µM), or Rosi (1 µM) were serum starved in 0.25% FBS containing DMEM 
for 1 h. The cells were stimulated with or without ISO (1 μM) for further 6 h. PKA 
activities were measured from total cell lysates using DetectX PKA activity kit (Arbor 
Assays, Ann Arbor, MI) according to the manufacturer’s instructions.  
Western blot analysis 
Total cell lysates were prepared using 1X lysis buffer (Cell Signaling, Danvers, 
MA) and protein concentration were determined by the BCA assay kit (Thermo 
Scientific, Waltham, MA). Twenty micrograms of total cell lysates were subjected to 
10% SDS-PAGE and transferred to polyvinylidene difluoride membrane (Bio-Rad, 
Hercules, CA). The membrane was blocked in 20 mM Tris·HCl, 137 mM NaCl, and 
0.1% Tween 20 (pH 7.4) containing 5% nonfat milk. The membrane was immunoblotted 
with primary antibodies at 4°C overnight followed by secondary antibody conjugated 
with horseradish peroxidase for 1 h. The membrane was exposed on X-ray film after 
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developed by ECL Western blot detection reagents (GE Healthcare, Piscataway, NJ). 
The membranes was stripped in stripping buffer (62.5 mM Tris-HCl, 2 % SDS, and 100 
mM 2-mercaptoethanol) at 50 °C for 10 min. 
RNA preparation and quantitative real-time PCR analysis 
Total RNA was prepared using TRI reagent (Molecular Research Center, 
Cincinnati, OH) according to the manufacturer’s instructions. Total RNA abundance was 
quantified using NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, 
Wilmington, DE). Reverse transcription was carried out using High capacity cDNA 
Reverse Transcription kit (Thermo Scientific, Pittsburgh, PA) according to the 
manufacturer’s instructions. mRNA expression of target genes and the housekeeping 
gene 36B4 was measured quantitatively using Absolute Blue QPCR SYBR Green ROX 
mix (Thermo Fisher Scientific, location). PCR reactions were run in a 96-well format 
using an ABI 7300HT instrument. Cycle conditions were 50°C 2 min, 95°C 15 min and 
then 40 cycles of 95°C for 15 s/60°C for 1 min. Relative gene expression was calculated 
using the 2-ΔΔCt method (Dawson et al., 2012), which normalizes against a house 
keeping gene 36B4. 
Reporter gene assays 
3T3-L1 preadipocytes were seeded in 24-well plates were transiently transfected 
with PPAR response element-driven luciferase reporter (PPRE-Luc) (PPRE-Luc was a 
gift from Bruce Spiegelman (Addgene plasmid # 1015) or murine PPARγ ligand binding 
domain (LBD) coupled to the Gal4 DNA binding domain (DBD) (mPPARγ-Gal4) and a 
reporter construct containing an upstream activating sequence linked luciferase, 
4xUAS-TK-luc (TK: thymidine kinase) (gifts from Dr Susanne Mandrup at University of 
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Southern Denmark, Denmark) (Taxvig et al., 2012) with Fugene HD transfection 
reagent (Promega, Madison, WI). The cells were then treated with naringenin or the 
vehicle control DMSO for 18 h. Reporter luciferase activities were measured from cell 
lysates with GloMax Luminometer (Promega, Madison, WI). Relative luciferase activities 
were normalized by total protein concentrations measured by BCA assay kit. 
Cellular bioenergetics measurements 
3T3-L1 preadipocytes were differentiated in the presence or absence of 
naringenin, or Rosi for 7 days. Then adipocytes were replated and seeded in 24-well XF 
assay plates in DMEM containing 10% FBS for overnight followed by treated with ISO 
(1 μM) for 6 h. After treatment, cells were rinsed with XF assay buffer (DMEM without 
NaHCO3, 10 mM glucose, 2 mM pyruvate, and 2 mM GlutaMAX, pH 7.4) 3 times. A 500 
μl of XF assay buffer was then added into each well, and equilibrated at non-CO2 
incubator at 37°C for 1 h. Real-time measurements of oxygen consumption rate (OCR) 
was conducted using XF24 Extracellular Flux Analyzer (Seahorse Biosciences, North 
Billerica, MA). For the mitochondria stress test, mitochondrial complex inhibitors were 
injected to sequentially in the following order: oligomycin (1 μM), carbonyl cyanide-
ptrifluoromethoxyphenylhydrazone (FCCP; 0.75 μM), antimycin A/rotenone (1 μM 
each), and 3 readings were taken after each injection. OCR was automatically recorded 
by XF24 software v1.8 provided by the manufacturer.  
Calculations of proton leak, coupling efficiency, maximal respiration, and ATP 





All data are presented as mean±SE. Measurements were performed in 
triplicates. Statistical analysis was performed using SigmaPlot 13.0 (Systat Software). 
One-way ANOVA with repeated measures followed by multiple comparisons test 
(Student-Newman-Keuls method) was performed to determine the differences of group 
mean between the treatment groups and/or time points. Student’s t-tests were 





Naringenin dose-dependently enhances UCP-1 and PGC-1α mRNA in ISO-
stimulated 3T3-L1 adipocytes.  
To investigate the browning effect of naringenin on white adipocytes, 3T3-L1 
cells were differentiated in the presence or absence of naringenin (5, 10 μM). Rosi was 
included as a positive control in the studies. At basal (e.g., non-stimulated) condition, 
Rosi induced mRNA expression of established brown specific markers UCP-1, PGC-1α, 
and induced novel brown marker PRDM16, and suppressed Meox-2, as reported 
(Petrovic et al., 2010). Also, Rosi suppressed white specific marker IGFBP3, as 
reported (Petrovic et al., 2010). In contrast, naringenin did not increase UCP-1 and 
PGC-1α mRNA even when used up to 20 µM at the basal condition (data not shown); 
however, at 10 µM, naringenin significantly increased mRNA expression of PRDM16 
and suppressed Meox-2 and IGFBP3 mRNA (Figure 17A).  
When stimulated with isoproterenol (ISO), naringenin at 10 μM, significantly 
promoted ISO-induced UCP-1 activation, as demonstrated by the enhanced mRNA 
expression of brown adipocyte specific genes, UCP-1 and PGC-1α (Figure 17B). 
Naringenin enhances thermogenesis in ISO-stimulated 3T3-L1 adipocytes. 
To determine whether the upregulation of UCP-1 mRNA by naringenin leads to 
increase in mitochondrial uncoupling and thermogenesis, we examined oxygen 
consumption rates coupled with mitochondrial stress tests in ISO-stimulated 3T3-L1 
adipocytes which have been differentiated in the presence or absence of naringenin by 
cellular bioenergetics measurements using XF24 Extracellular Flux Analyzers (Figure 
18A-D). Naringenin at 10 μM significantly increased isoproterenol-stimulated oxygen 
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consumption from proton leak (Figure 18A) and decreased coupling efficiency (Figure 
18B); however, naringenin did not affect the ISO-stimulated maximal respiration (Figure 
18C) and oxygen consumption from ATP production (Figure 18D). 
Naringenin enhances isoproterenol-stimulated PKA activation and 
phosphorylation of p38 MAPK.  
Beta-adrenergic activation induces increase in cAMP levels, leading to PKA 
activation and downstream p38 MAPK phosphorylation. ISO stimulation resulted in ~3 
folds of PKA activities, compared to non-stimulated controls in mature 3T3-L1 
adipocytes (Figure 19). Both Rosi and naringenin induced significant enhancement of 
PKA activation induced by ISO (Figure 19).  
We next examined whether naringenin treatment during 3T3-L1 adipocytes 
differentiation affects p38 MAPK phosphorylation downstream of ISO stimulation. 
Western analysis showed that ISO induced a peak of p38 phosphorylation at 15 min 
upon the stimulation (Figure 20). In contrast, p38 phosphorylation was higher at the 
basal state (time 0), and was significantly enhanced in naringenin treated 3T3-L1 
adipocytes stimulated by ISO. Rosi induced the highest p38 MAPK phosphorylation at 
the basal state and throughout the 60 min in 3T3-L1 adipocytes (Figure 20). 
Naringenin activates PPRE reporter gene and transactivates PPARγ in 3T3-L1 
cells.  
To understand whether naringenin’s effects were mediated through PPARγ, we 
performed reporter gene assays. Naringenin at 10 µM activated PPRE-Luc reporter up 
to ~2 fold whereas Rosi induced ~3.5 fold compared to the controls in 3T3-L1 (Figure 
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21A). In addition, naringenin at the same concentration transactivated PPARγ in 3T3-L1 
cells (Figure 21B), consistent with the report (Goldwasser et al., 2010). 
Enhancement of UCP-1 mRNA by naringenin is attenuated by inhibition of either 
PKA or p38 MAPK.  
To investigate whether the activation of PKA/p38 MAPK underlies ISO-stimulated 
UCP-1 activation by naringenin, we employed the pharmacological inhibitors of PKA 
H89 and p38 MAPK SB203580. The PKA inhibitor H89 blocked UCP-1 mRNA 
expression at the basal state and the upregulation induced by naringenin and Rosi. The 
p38 MAPK inhibitor SB203580 also significantly blocked basal as well as naringenin 






Increasing functional brown adipose activities has become novel targets for 
obesity treatment and prevention. Naringenin, a citrus flavanone, has been reported to 
be beneficial in obesity and obesity associated chronic diseases. Here, we report that 
naringenin dose-dependently enhances ISO-stimulated UCP-1 mRNA. Naringenin at 10 
µM significantly increased ISO-induced uncoupled respiration from proton leak, but 
decreased coupled efficiency, consistent with the enhancement on UCP-1 activation in 
ISO-stimulated 3T3-L1 adipocytes by naringenin. Furthermore, naringenin enhanced 
PKA activation and phosphorylation of p38 MARK downstream of ISO. Inhibition of 
either PKA or p38 MARK blocked naringenin’s enhancement of ISO-stimulated UCP-1 
activation. Our studies suggest that naringenin promotes ISO-stimulated thermogenic 
activation of 3T3-L1 adipocytes via PKA/p38 MARK pathways (Figure 23).  
3T3-L1 cell model, representing a very “white” cell model (Jun Wu & Spiegelman, 
2014), has been used for identifying strategies to induce browning, i.e., acquiring of 
brown-like adipocyte characteristics. Recent studies have suggested that 3T3-L1 cells 
have the ability to induce UCP-1 and markers of beige adipocytes under specific 
environmental conditions. β-adrenergic activation by isoproterenol, a nonspecific β-
adrenergic agonist, induces thermogenic activation in brown adipocytes and brown 
adipose tissue. It has been reported that 3T3-L1 adipocytes differentiated from standard 
differentiation protocol has significant increase of UCP-1 expression in response to ISO 
(Asano et al., 2014). ISO induced a much higher UCP-1 expression in 3T3-L1 
adipocytes treated with T3, Rosi and IBMX (Asano et al., 2014). Moreover, ISO at 100 
µM also enhanced UCP-1 expression, leading to increased oxygen consumption rate in 
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3T3-L1 adipocytes differentiated from standard differentiation protocol supplemented 
with only T3 (Miller et al., 2015). To our knowledge, our finding is the first to report a 
dietary bioactive compound naringenin at 10 µM enhances ISO-stimulated thermogenic 
activation in 3T3-L1 adipocytes.  
It is generally believed that the most critical test for functional brown adipocytes 
is the ability to display induced thermogenesis by adrenergic activation (Petrovic et al., 
2010). The findings that naringenin did not induce UCP-1 expression at the basal state, 
but enhanced UCP-1 activation and thermogenesis in response to ISO suggest that 
naringenin promotes the development of functional brown adipocytes. The effect of 
naringenin is in contrast with some of the reported “browning” agents, such as PPARγ 
agonist Rosi, and Irisin. Rosi induced UCP-1 expression not only at the basal state but 
also ISO-stimulated condition in primary adipocytes differentiated from stromal vascular 
fraction of white fat (Petrovic et al., 2010). In our studies, we have included Rosi as a 
positive control. We show that Rosi induced UCP-1 mRNA at both basal and ISO-
stimulated condition in 3T3-L1 adipocytes. Recombinant form of Irisin, a newly identifies 
hormone secreted from skeletal muscles, upregulated UCP-1 expression in 3T3-L1 
adipocytes at the basal state and induced browning of subcutaneous fat pads when 
injected into the mice (Zhang et al., 2014). However, whether Irisin enhances ISO-
stimulated UCP-1 activation and thermogenesis has not been reported. It is worthy of 
noting that naringenin exposure during differentiation increased PRDM16 mRNA and 
suppressed mRNA expression of Meox-2, and IGFBP3, similar to those of Rosi at the 
basal state, suggesting that naringenin promotes the acquiring of some of the 
characteristics of brown-like adipocytes induced by Rosi. However, it remains to be 
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determined whether naringenin induces development of functional brown adipocytes in 
vivo. 
To explore the mechanisms by which naringenin promotes ISO-stimulated 
thermogenic activation, we examined the effects on naringenin on the signaling events 
downstream of ISO. It has been reported that adrenergic activation in brown adipocytes 
induces cAMP accumulation, leading to PKA activation, which indirectly leads to 
phosphorylation and activation of p38 MAPK. Activation of p38 leads to upregulation 
and activation of PGC-1α, coactivator of PPARγ on the PPRE site in the promotor of 
UCP-1 gene, leading to UCP-1 transcription (Cao et al., 2004; Cao, Medvedev, Daniel, 
& Collins, 2001). Our results indicate that naringenin enhanced PKA activation 
downstream of ISO to a level that is similar to that of Rosi. Moreover, naringenin 
exposure induced a higher level of phosphorylation of p38 at the basal state and further 
enhanced phosphorylation of p38 stimulated by ISO. We also show, for the first time, 
that Rosi also enhanced basal phosphorylation of p38 to a much higher level and further 
maintained a strong phosphorylation of p38 stimulated with ISO. Phosphorylation of p38 
MAPK leads to upregulation of PGC-1α transcription and enhanced interaction between 
PGC-1α and PPARγ, leading to UCP-1 transcription in response to ISO (Cao et al., 
2004; Cao et al., 2001). Our results demonstrating enhanced upregulation of PGC-1α 
mRNA and increased of PPARγ transactivation by naringenin are consistent with the 
effects of enhanced phosphorylation of p38 by naringenin. Furthermore, we show that 
inhibition of PKA or p38 suppressed ISO-stimulated UCP-1 activation. Together, these 
results suggest that the enhancement of ISO-stimulated thermogenic activation by 
naringenin is mediated through PKA/p38 MAPK pathways (Figure 23).  
150 
 
In conclusion, we have demonstrated that naringenin at 10 µM enhances ISO-
stimulated UCP-1 activation and thermogenesis in 3T3-L1 adipocytes, possibly through 
enhancement of PKA/p38 MAPK pathways downstream of ISO. Our results suggest 
that naringenin may be beneficial in promoting activities of functional brown adipose 
tissue in vivo. Further studies of naringenin in the development of functional brown 
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Figure 17 Effect of naringenin on mRNA expression of brown adipose specific 
markers 
3T3-L1 preadipocytes were induced to differentiation in the presence of various doses 
of naringenin (NAR, 0, 5, 10 µM) for 7 days. On day 7, matured 3T3-L1 adipocytes were 
treated with or without isoproterenol (ISO) for 6 h. Total RNA was extracted and mRNA 
expression of target genes were quantified and normalized by 36B4. The relative mRNA 
expression was expressed as fold of changes compared to that of DMSO control (-, set 
as 1). (A) mRNA expression of brown adipose specific markers UCP-1, PGC-1α, 
PRDM16, novel brown marker Meox-2, and white adipose specific markers IGFBP3 at 
basal level; (B) mRNA expression of thermogenic markers UCP-1 and PGC-1α at ISO-
stimulated level. Rosiglitazone (Rosi) was used as a positive control. Data were 







Figure 18 Effect of naringenin on mitochondrial respiration in isoproterenol 
induced 3T3-L1 adipocytes 
3T3-L1 cells were differentiated in the presence or absence of naringenin (NAR, 10 µM) 
until day 7. The cells were then sub-cultured in 24-well XF assay plates overnight, 
followed by stimulation of isoproterenol (1µM) for 6 h. Real-time measurements of 
oxygen consumption rate (OCR) coupled with mitochondrial stress tests were 
conducted. The mitochondrial complex inhibitors were injected sequentially in the 
following order: oligomycin (1 µM), FCCP (0.75 µM), antimycin A/rotenone (1 µM each), 
and three readings were taken after each inhibitor. (A) OCR from proton leak, (B) 
coupling efficiency, (C) maximal respiration, and (D) ATP production. Rosiglitazone 
(Rosi) was used as a positive control. Data were presented as mean±SE (n=3). *, 






Figure 19 Effect of naringenin on PKA activation 
3T3-L1 cells were differentiated in the presence or absence of naringenin (NAR, 10 µM) 
followed by costimulated with or without isoproterenol for 6 h. Total cell lysate was 
prepared and PKA activity was measured as described in materials and methods. 
Rosiglitazone (Rosi) was used as a positive control. Data were presented as mean±SE 






Figure 20 The effect of naringenin on the phosphorylation of p38 MAPK 
3T3-L1 cells were differentiated in the presence or absence of naringenin (NAR, 10 µM) 
until day 7 followed by isoproterenol treatment for different times as indicated in the 
figure. Total cell lysate was prepared and analyzed by Western blot with specific 
antibodies against phospho-p38 MAPK and total-p38 MAPK. Rosiglitazone (Rosi) was 
used as a positive control. The experiments were performed 3 times. Results from a 






Figure 21 Effect of naringenin on PPARγ and PPRE transactivation 
3T3-L1 preadipocytes were transfected with (A) PPARγ-gal4 and (B) PPRE 
transactivation reporters. Cells were treated with or without naringenin (NAR, 10 µM) for 
18 h in 0.25% FBS containing DMEM. Cell lysate was prepared and reporter gene 
assay performed. Rosiglitazone (Rosi) was used as a positive control. PPRE 
transactivation normalized by total protein concentration is presented as fold of that of 
the control (set as 1). Data were presented as mean±SE (n=3). *, significantly different 





Figure 22 Regulation of UCP-1 gene expression by pharmacological inhibitors for 
PKA/p38 MAPK signaling pathway 
3T3-L1 cells were differentiated in the presence of naringenin (NAR, 10 µM) or 
rosiglitazone (Rosi) until fully differentiated. The differentiated cells were pretreated with 
PKA inhibitor H-89 (20 µM), SB203580 (10 µM), or DMSO for 1 h followed by 
isoproterenol (1 μM) treatment for 6 h. Rosiglitazone (Rosi) was used as a positive 
control. mRNA expression of UCP-1 was evaluated by semi-quantitative RT-PCR. The 
relative mRNA expression was normalized with 36B4 and expressed as fold of the 
vehicle value (set as 1). Data were presented as mean±SE (n=3). *, significantly 






Figure 23 Schematic diagram of activation of β-adrenergic receptor-stimulated 




CONCLUSION AND FUTURE DIRECTION 
 
In this dissertation, it has been reported that (1) mRNA of selected PRRs and 
inflammatory cytokines/chemokines are upregulated in the BAT of both DIO and ob/ob 
mice; (2) activation of PPRs induces activation of NF-κB and MAPK signaling pathways, 
leading to upregulation of the proinflammatory genes MCP-1, IL-6, RANTES, and TNF-α 
in mature brown adipocytes; (3) activation of PRRs suppresses UCP-1 expression, 
leading to decreased mitochondrial respiration and thermogenesis in mature brown 
adipocytes; (4) chronic activation of PRRs reduces adipogenesis and suppresses 
expression of brown-specific genes in both classic brown adipocytes and multipotent 
stem cells, suggesting that chronic activation of PRRs negative affect BAT 
development; lastly, (5) naringenin, a citrus flavanone, enhances thermogenic activation 
in isoproterenol-stimulated 3T3-L1 adipocytes through PKA/p38 MAPK activation.  
Our results suggest that PRR-mediated inflammation in brown adipocytes may 
be potential targets to regulate BAT development and function for obesity treatment and 
prevention. Dietary bioactive compound naringenin may be beneficial in promoting 
functional BAT, contributing to energy expenditure. 
In the future, the studies of the role of PRRs in brown adipose inflammation in 
vivo using the animal models would be needed to confirm the results using the cell 
culture models reported in chapter I and II. Selected PRR knockout animal with high fat 
diet could be used to determine the role of PRR in brown adipose inflammation and 
obesity. Since specific PRR knockout mice have been used to examine body weight, 
plasma inflammatory cytokines, and adipose inflammation in WAT, BAT inflammation 
and function can be examined in the same animal models. Moreover, these models can 
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be used to screen dietary bioactive compounds with anti-inflammatory properties for the 
activities to reduce BAT inflammation and promote BAT development and function. 
Furthermore, the effects of naringenin in promoting thermogenic activation in white 
adipocytes should be tested and extended in the animal models. Successful completion 
of naringenin studies in these preclinical models will provide justification to test the 
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